DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	NCR3; IL18RAP; LY86; ORM1; S100A8; FOLR2; CD40LG; FCGR2B; CNR2; CXCR3; AIF1; NLRP6; S100A12; MS4A2; FUT7; NAIP; IL18; PLD4; CD180; PROK2; IL23A; STAB1; PF4; PTGDR; ACKR1; PF4V1; CCR5; XCL1; CCR2; XCL2; IL2RA;	GO:0006954~inflammatory response	31	381	8.13648293963255	0	0	0	0	0	0	0
up	IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; IGLV7-43; IGKV3-11; IGKV4-1; IGHV4-34; IGLC2; IGLC3; IGHV1-2; IGLV3-21; IGHV1-18; TRDC; IGHV3-21; IGHV5-51; IGHD; IGHV3-49; TRBC2; IGLL5; IGHV3-15; TRBC1; IGHV3-74; IGHV1-3; IGHA2;	GO:0006958~complement activation, classical pathway	49	161	30.4347826086957	0	0	0	0	0	0	0
up	LILRA1; IL2RA; CD3D; ADRB2; CD3G; CXCR1; KLRC1; CXCR3; CCR5; ADGRE1; ADGRF1; ADGRF2; LILRB2; CLEC1A; ADGRE3; CLEC1B; CLEC4A; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; TRBV6-1; TRBV27; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV25-1; TRBV7-2; TRBV4-1; TRBV7-6; TRBV29-1; TRBV15; TRBV30; TRBV10-2; TRBV4-2; TRBV20-1; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV5-4; TRBV9; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	51	268	19.0298507462687	0	0	0	0	0	0	0
up	HP; S100A8; ELANE; S100A12; IRF8; CEBPE; STAB1; IGHV3-48; IGHG2; IGLC3; IGHG3; IGHV1-46; TRBC1; IGHV1-2; TRBC2; IGHV3-30; IGHA2; IGLC2; IGLL5; IGHV2-5; IGHD; IGHV3-49; IGHV3-74; IGHV1-18; IGHV3-7; GSDMC; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-23; TRDC; IGKC; IGHV4-39; IGHV3-21; IGHV3-11; IGHV1-3; IGHG4;	GO:0042742~defense response to bacterium	37	216	17.1296296296296	0	0	0	0	0	0	0
up	TRGV2; TRDV2; LILRA5; CD300LB; TYROBP; LY86; JCHAIN; C1QA; C1QB; TRGV3; S100B; S100A8; RNASE3; DEFA4; KIR2DS4; NLRP6; LILRA4; S100A12; SIGLEC14; NAIP; SLAMF1; CD300E; CLEC10A; ZNF683; LILRA2; CLEC4C; RNASE6; PLD4; SIGLEC10; CD180; TRGV9; IL23A; TLR8; LYAR; TLR7; CD84; CLEC4A; POLR3K; TRDC; IGHV3-15; IGHV3-48; IGHV3-23; IGHV4-39; TRBC1; IGHV1-3; TRBC2; IGHV3-30; IGLC3; IGHV3-49; IGHV1-2; IGHV3-21; IGHV5-51; IGHV3-7; IGHV1-18; IGHV1-46; IGHG4; IGHA2; IGLL5; IGLC2; IGHV3-74; IGHG3; BPI; IGHV3-11; IGHV4-34; IGKC; IGHV2-5; IGHD; IGHG2;	GO:0045087~innate immune response	68	505	13.4653465346535	0	0	0	0	0	0	0
up	TRAV19; CD300LB; NCR3; TYROBP; LILRA1; NCR1; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; TRBV12-3; TRAV8-4; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGKC; TRBC1; IGLV7-43; CD3D; IGKV3-11; TRBV7-9; TRAV29DV5; CD1A; IGKV4-1; IGHV4-34; CD3G; IGLC2; IGLC3; CD8B; CD19; IGHV1-2; KLRC1; CD1C; CD40LG; FCGR2B; ICAM3; KIR2DL1; KIR2DL3; KIR3DL1; KIR3DL2; IGLV3-21; CD300E; TREML2; LAIR2; CLEC4G; LILRB2; LILRB1; RAET1E; CD300LF; CD300A; SIGLEC7; BTNL8;	GO:0050776~regulation of immune response	67	216	31.0185185185185	0	0	0	0	0	0	0
down	FOXE1; MEIS2; TBX3; SNAI2; SOX15; IL33; TFAP2A; GLI3; BMP4; HOXD8; EFNA1; FGFR2; CCND1; NR2F2; MSX1; HOXC8; MSX2; FRK; SOX2; SOX9; HMGA2; PLK1; PRRX1; FOXA1; FOXL2; ISL1; NKX3-2; CAV1; SREBF2; TBX2; TRIM29; SIM2; FHL2; HES1; CBX2; CRYM; SIX1; DAB2IP; KCTD1; OSR1; PPP1R13L; TFAP2C; PROX1; AJUBA; MDFI; SMO; FOXC2; IRX2; WWTR1; TP63; TENM2; TFCP2L1; LMCD1; TAGLN3; KCNIP3; LOXL2; DLX2; NFIB; TBX18; HES2; TBX1; ZFHX4; RIPPLY3;	GO:0000122~negative regulation of transcription by RNA polymerase II	63	847	7.43801652892562	0	0	0	0	0	0	0
down	DAPL1; DLL1; TLL1; SOX15; INHA; FGF1; MGP; MAL; MDK; FOXL2; BNC1; NHLH2; MECOM; SIM2; CBX2; SHB; CSRP2; ZNF423; ZNF750; NXN; CXCL17; TXNRD3; EGFL6; ARHGEF28; OSR1; TWIST2; EDARADD; PTPRU; MMP19; CADM1; DHCR7; NDRG4; JAG2; DLX2; POU3F1; NKX2-8; KIAA1522; NR2F2; FOXA2; FOXA1; ETV5; ETV4; CAV1; FOXD4; HES1; FOXC2; NKX3-2; HNF4G; EYA2; ELF5; FOXD1; FSTL1; SOX2; FRK; SOX7; HES2; NKX1-2; SOX21; ELF3; CAV2; FOXE1;	GO:0030154~cell differentiation	61	572	10.6643356643357	0	0	0	0	0	0	0
down	UNC13B; GJA1; SLC1A3; SLC1A1; STXBP1; NTRK2;	GO:0014047~glutamate secretion	6	30	20	0.00010313073054035	0.00188411911564114	0.370651845562044	0.391896776053358	0.249163844985503	0.370548714831504	0.0166181257641581
down	MSX1; MSX2; HMGA2; SHC4; OSR1; SOX21;	GO:0048863~stem cell differentiation	6	30	20	0.00010313073054035	0.00188411911564114	0.370651845562044	0.391896776053358	0.249163844985503	0.370548714831504	0.0166181257641581
down	ITGA2; EDN2; CTTN; ADRA1B; ADRA1D;	GO:0045987~positive regulation of smooth muscle contraction	5	18	27.7777777777778	0.00010553307255878	0.00190964607487322	0.378969263558591	0.401025675723377	0.252124361404919	0.378969263558591	0.0168432761887643
up	SPI1; IRF4; BATF; BATF3;	GO:0043011~myeloid dendritic cell differentiation	4	18	22.2222222222222	0.00010746122581206	0.00331159677544185	0.192355594203599	0.198695806526511	0.172725050776078	0.192355594203599	0.026823557313962
down	SERPINE2; PTN; NTRK2; SYT12; PLK2; SHANK2; SHANK3;	GO:0060291~long-term synaptic potentiation	7	45	15.5555555555556	0.00011233469570604	0.00202308930655428	0.403281557584684	0.426871843682952	0.260616494038013	0.403281557584684	0.0178438572430713
up	ELANE; FLT3; S100A12; PIK3R6; EPGN; PIK3R5;	GO:0043406~positive regulation of MAP kinase activity	6	60	10	0.00011436247866458	0.00346649545984953	0.204594474330946	0.211456223050821	0.180235266375389	0.204594474330946	0.0280782190438799
down	BCHE; FOSL1; PTN; SLC6A1; NTRK2; SHANK3; PAK6; SHANK2;	GO:0007612~learning	8	62	12.9032258064516	0.00012028919029993	0.00212666577090654	0.431597614796178	0.457098923139765	0.269231992161929	0.431597614796178	0.0187574123875013
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.00012070639145256	0.00354263679040935	0.215823027917183	0.223186117795789	0.187094906751473	0.21570232152573	0.0286949551632585
up	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.00012070639145256	0.00354263679040935	0.215823027917183	0.223186117795789	0.187094906751473	0.21570232152573	0.0286949551632585
down	MID1; TBX1; LHX1; SIX1; SOSTDC1; SHROOM3;	GO:0007389~pattern specification process	6	31	19.3548387096774	0.00012088415960942	0.00212666577090654	0.433611480519006	0.459359806515813	0.269896969988747	0.433369712199787	0.0187574123875013
down	HOXC6; WNT5A; NKX3-2; HOXC5; KIAA1217; SULF1;	GO:0048706~embryonic skeletal system development	6	31	19.3548387096774	0.00012088415960942	0.00212666577090654	0.433611480519006	0.459359806515813	0.269896969988747	0.433369712199787	0.0187574123875013
down	TBX1; MMP2; MSX1; PAX9; CRISPLD1; LRP6;	GO:0060325~face morphogenesis	6	31	19.3548387096774	0.00012088415960942	0.00212666577090654	0.433611480519006	0.459359806515813	0.269896969988747	0.433369712199787	0.0187574123875013
down	MATN2; P2RY1; CSPG4; NDN;	GO:0008347~glial cell migration	4	9	44.4444444444444	0.00012483109444472	0.00214641700855178	0.447269811395438	0.474358158889943	0.274129083400609	0.446895318112104	0.0189316203494404
down	FBN1; MFAP2; FOXL2; EFEMP1;	GO:0048048~embryonic eye morphogenesis	4	9	44.4444444444444	0.00012483109444472	0.00214641700855178	0.447269811395438	0.474358158889943	0.274129083400609	0.446895318112104	0.0189316203494404
down	SIX1; NET1; SMO; SIX4;	GO:0051451~myoblast migration	4	9	44.4444444444444	0.00012483109444472	0.00214641700855178	0.447269811395438	0.474358158889943	0.274129083400609	0.446895318112104	0.0189316203494404
down	WNT5A; LHX1; FOXA2; LRP6;	GO:0090009~primitive streak formation	4	9	44.4444444444444	0.00012483109444472	0.00214641700855178	0.447269811395438	0.474358158889943	0.274129083400609	0.446895318112104	0.0189316203494404
up	LTF; RNASE3; DEFA3; DEFA4;	GO:0002227~innate immune response in mucosa	4	19	21.0526315789474	0.00012890300767787	0.00372408845619352	0.230220771712679	0.238341661196385	0.195545862647332	0.230220771712679	0.0301646930229429
down	ITGA2; POSTN; SEMA6D; HAS2; NOX4;	GO:0014911~positive regulation of smooth muscle cell migration	5	19	26.3157894736842	0.00013097333860134	0.00220791943534404	0.468622605515623	0.497698686685122	0.280675864622688	0.46836065883842	0.0194740781244027
down	LRP4; MDK; SOX9; SFRP1; KREMEN2;	GO:0030279~negative regulation of ossification	5	19	26.3157894736842	0.00013097333860134	0.00220791943534404	0.468622605515623	0.497698686685122	0.280675864622688	0.46836065883842	0.0194740781244027
down	HRAS; CSF3; BAIAP2L1; BAIAP2L2; BAIAP2;	GO:2000251~positive regulation of actin cytoskeleton reorganization	5	19	26.3157894736842	0.00013097333860134	0.00220791943534404	0.468622605515623	0.497698686685122	0.280675864622688	0.46836065883842	0.0194740781244027
down	DLL1; WNT5A; TBX2; SMO; VANGL2; NDRG4; TBX1; TBX3;	GO:0001947~heart looping	8	63	12.6984126984127	0.00013305619755099	0.00220791943534404	0.475409793849708	0.505613550693784	0.282890905402675	0.475276737652157	0.0194740781244027
down	LRP5; YAP1; SOX2; SOX9; HES1; SFRP1; ELF5; VANGL2;	GO:0035019~somatic stem cell population maintenance	8	63	12.6984126984127	0.00013305619755099	0.00220791943534404	0.475409793849708	0.505613550693784	0.282890905402675	0.475276737652157	0.0194740781244027
down	CDH13; CCBE1; PARVA; LOXL2; KDR; VEGFC;	GO:0002040~sprouting angiogenesis	6	32	18.75	0.00014097678464064	0.00231909862179416	0.503428097951744	0.535711781634451	0.291399013852213	0.503287121167103	0.0204546900652546
down	TSPAN12; ERBB2; EFNA1; EPHA2; EMP2; SFRP1;	GO:0045765~regulation of angiogenesis	6	32	18.75	0.00014097678464064	0.00231909862179416	0.503428097951744	0.535711781634451	0.291399013852213	0.503287121167103	0.0204546900652546
down	LRP5; LRP6; AREG; GJA1; BMP7; GNAI1; ANXA1;	GO:0043434~response to peptide hormone	7	47	14.8936170212766	0.00014332749304979	0.00233752992956746	0.511535822694715	0.544644473589218	0.293937501708748	0.511392495201665	0.0206172561089998
down	FGF1; FGF5; PTN; MDK; FGFR2; VEGFC; GAREM1;	GO:0051781~positive regulation of cell division	7	47	14.8936170212766	0.00014332749304979	0.00233752992956746	0.511535822694715	0.544644473589218	0.293937501708748	0.511392495201665	0.0206172561089998
up	VIL1; MS4A1; GZMA; FCGR2B; CD79B; RGS1; NLRP6;	GO:0009617~response to bacterium	7	92	7.60869565217391	0.00015375458848276	0.00437372667853291	0.274451940441742	0.284292234104639	0.219443551104143	0.274451940441742	0.035426688752461
down	NGFR; NTF4; BCAR1; NTRK2; NDN;	GO:0048011~neurotrophin TRK receptor signaling pathway	5	20	25	0.00016085470009008	0.00260105472486095	0.573768715221333	0.611247860342323	0.310610425873954	0.573607860521243	0.0229415721003861
down	CLDN7; NTN1; TF; DUOXA2; DUOX1;	GO:2000147~positive regulation of cell motility	5	20	25	0.00016085470009008	0.00260105472486095	0.573768715221333	0.611247860342323	0.310610425873954	0.573607860521243	0.0229415721003861
down	GLI3; BMP4; HES1; TMEM17; DZIP1; SMO; BOC; B9D1;	GO:0007224~smoothened signaling pathway	8	65	12.3076923076923	0.00016195167553956	0.00260769647055227	0.577357723298539	0.615416367050337	0.311605714698577	0.577357723298539	0.0230001529853608
down	DLL1; NOS1; YAP1; CX3CL1; HES1; HES2;	GO:0050767~regulation of neurogenesis	6	33	18.1818181818182	0.00016362368986866	0.00262350220042583	0.583154830691918	0.621770021500923	0.313195958699808	0.583154830691918	0.023139561160063
up	JCHAIN; IGKC; IGHG3; IGHA2; LTF;	GO:0001895~retina homeostasis	5	40	12.5	0.00016540988006508	0.0046206529910837	0.295091226036106	0.305842868240336	0.229423503650268	0.295091226036106	0.0374267638057252
up	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.00017096214856582	0.0046206529910837	0.304825510892862	0.316109012698207	0.234149095165343	0.304654548744297	0.0374267638057252
up	HP; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	3	7	42.8571428571429	0.00017096214856582	0.0046206529910837	0.304825510892862	0.316109012698207	0.234149095165343	0.304654548744297	0.0374267638057252
down	HOXC11; FGF1; GDNF; SIX1;	GO:0001759~organ induction	4	10	40	0.00017181846289471	0.00270917078423199	0.612189183293862	0.652910158999909	0.320528284916652	0.611673727905178	0.0238951669431101
down	AXL; WNT5A; LHX1; TYRO3;	GO:0060068~vagina development	4	10	40	0.00017181846289471	0.00270917078423199	0.612189183293862	0.652910158999909	0.320528284916652	0.611673727905178	0.0238951669431101
down	HOXC11; BMP4; BMP7; OSR1;	GO:0060272~embryonic skeletal joint morphogenesis	4	10	40	0.00017181846289471	0.00270917078423199	0.612189183293862	0.652910158999909	0.320528284916652	0.611673727905178	0.0238951669431101
down	SPRY2; DCN; XDH; DAB2IP;	GO:1900747~negative regulation of vascular endothelial growth factor signaling pathway	4	10	40	0.00017181846289471	0.00270917078423199	0.612189183293862	0.652910158999909	0.320528284916652	0.611673727905178	0.0238951669431101
down	TLL1; MMP2; MMP10; LAMC1; KLK7; MMP16; MMP19; KLK5;	GO:0022617~extracellular matrix disassembly	8	66	12.1212121212121	0.00017822591345195	0.00279086245322026	0.634306025975515	0.677258471117437	0.325950183417253	0.634306025975515	0.0246156959255195
down	KLK8; LRP4; NFASC; WNT7B; PCDHGC3; PCDHGC5; PPFIBP1;	GO:0050808~synapse organization	7	49	14.2857142857143	0.0001809070529295	0.00279086245322026	0.643667294323168	0.687446801132108	0.328165394014117	0.643667294323168	0.0246156959255195
down	SFN; KDF1; TP63;	GO:0010482~regulation of epidermal cell division	3	3	100	0.00018287493443469	0.00279086245322026	0.650486141784213	0.694924750851844	0.329849733948674	0.64957176711204	0.0246156959255195
down	SIX1; PROX1; SIX4;	GO:0030910~olfactory placode formation	3	3	100	0.00018287493443469	0.00279086245322026	0.650486141784213	0.694924750851844	0.329849733948674	0.64957176711204	0.0246156959255195
down	FZD6; MSX1; MSX2;	GO:0035880~embryonic nail plate morphogenesis	3	3	100	0.00018287493443469	0.00279086245322026	0.650486141784213	0.694924750851844	0.329849733948674	0.64957176711204	0.0246156959255195
down	FBN1; MFAP2; EFEMP1;	GO:0048050~post-embryonic eye morphogenesis	3	3	100	0.00018287493443469	0.00279086245322026	0.650486141784213	0.694924750851844	0.329849733948674	0.64957176711204	0.0246156959255195
down	EMP2; PDPN; PARVA;	GO:0070252~actin-mediated cell contraction	3	3	100	0.00018287493443469	0.00279086245322026	0.650486141784213	0.694924750851844	0.329849733948674	0.64957176711204	0.0246156959255195
down	BMP4; SOX9; SIX1;	GO:0072193~ureter smooth muscle cell differentiation	3	3	100	0.00018287493443469	0.00279086245322026	0.650486141784213	0.694924750851844	0.329849733948674	0.64957176711204	0.0246156959255195
down	HS6ST1; BMP4; HOXA5; EDN2; FGFR2; IGFBP5;	GO:0048286~lung alveolus development	6	34	17.6470588235294	0.00018905079547793	0.00287357209126453	0.671319374742128	0.718393022816133	0.334998009586891	0.671319374742128	0.025345203500448
down	LRP6; FOXA1; SFRP1; DMRTA2; FOXA2;	GO:0071542~dopaminergic neuron differentiation	5	21	23.8095238095238	0.00019567387131491	0.00295063774205033	0.694446569296638	0.743560710996682	0.340638519336627	0.694446569296638	0.0260249305231311
down	DLL1; EPN2; JAG1; ELF3; HES1; TP63; JAG2;	GO:0045747~positive regulation of Notch signaling pathway	7	50	14	0.00020247470495871	0.00304112205076324	0.718380253193505	0.7694038788431	0.346231745479395	0.718380253193505	0.0268230114986868
up	EREG; OSM; CD19; IL18; ANGPT1; TRAT1; EPGN; PIK3R5; ICOS;	GO:0051897~positive regulation of protein kinase B signaling	9	165	5.45454545454545	0.00020282879365096	0.00535757770658053	0.36103525269872	0.375030439460637	0.260837828635143	0.36103525269872	0.0433957702043279
up	IL2RA; CTLA4; CLEC4G; LILRB2; LILRB1;	GO:0042130~negative regulation of T cell proliferation	5	43	11.6279069767442	0.00022534189145506	0.00574576953033904	0.400883224898563	0.416657157300418	0.277629409124532	0.400883224898563	0.046540079834841
down	ITGB4; ITGA2; FGFR2; HMGA2;	GO:0048333~mesodermal cell differentiation	4	11	36.3636363636364	0.00023035247767788	0.00340598994231894	0.817060238323463	0.875339415175969	0.367272021395737	0.81636918089043	0.030041184096608
down	LAMA5; BMP7; FGFR2; LAMA1;	GO:0060445~branching involved in salivary gland morphogenesis	4	11	36.3636363636364	0.00023035247767788	0.00340598994231894	0.817060238323463	0.875339415175969	0.367272021395737	0.81636918089043	0.030041184096608
down	JUP; CAV1; DSG2; PKP2;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	4	11	36.3636363636364	0.00023035247767788	0.00340598994231894	0.817060238323463	0.875339415175969	0.367272021395737	0.81636918089043	0.030041184096608
down	WNT5A; FOXA1; PTPRU; FOXA2;	GO:2000049~positive regulation of cell-cell adhesion mediated by cadherin	4	11	36.3636363636364	0.00023035247767788	0.00340598994231894	0.817060238323463	0.875339415175969	0.367272021395737	0.81636918089043	0.030041184096608
up	SPINK5; OVOL1; OVOL2;	GO:0009913~epidermal cell differentiation	3	8	37.5	0.00023306258235555	0.00574576953033904	0.414385271428183	0.430932714775428	0.283404100144359	0.413686083681117	0.046540079834841
up	IL18RAP; IL18; LILRA2;	GO:0032635~interleukin-6 production	3	8	37.5	0.00023306258235555	0.00574576953033904	0.414385271428183	0.430932714775428	0.283404100144359	0.413686083681117	0.046540079834841
up	LTF; DEFA4; DEFA3;	GO:0051673~membrane disruption in other organism	3	8	37.5	0.00023306258235555	0.00574576953033904	0.414385271428183	0.430932714775428	0.283404100144359	0.413686083681117	0.046540079834841
up	ELANE; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	3	8	37.5	0.00023306258235555	0.00574576953033904	0.414385271428183	0.430932714775428	0.283404100144359	0.413686083681117	0.046540079834841
down	MELTF; IGFBP4; IGFBP5; BCAR1; DDR1; NET1; PAPPA2; WFDC1;	GO:0001558~regulation of cell growth	8	69	11.5942028985507	0.00023529377188591	0.0034485251569598	0.833645833791793	0.894116333166473	0.371038244552085	0.833645833791793	0.0304163490956992
down	APOE; DCN; NR2F2; STC1; DAB2IP;	GO:0010596~negative regulation of endothelial cell migration	5	22	22.7272727272727	0.00023595172126567	0.0034485251569598	0.835740996723004	0.896616540809547	0.371397621234084	0.835505045001739	0.0304163490956992
down	ITGA2; ITGB6; FBN1; ITGB4; ITGB5;	GO:0033627~cell adhesion mediated by integrin	5	22	22.7272727272727	0.00023595172126567	0.0034485251569598	0.835740996723004	0.896616540809547	0.371397621234084	0.835505045001739	0.0304163490956992
up	OVOL1; ELANE; GATA1; TAL1; PTPN2; SPI1; FST; FASLG; RORC; IRF8; HHEX; FOXC1; NRARP; WWC1; SDR16C5; NKAP; ZNF366; OVOL2; FOXQ1; BATF3; LYAR; TBX21; ZNF835;	GO:0000122~negative regulation of transcription by RNA polymerase II	23	847	2.71546635182999	0.00023908647560932	0.00581672228160065	0.42413940773095	0.44207089340165	0.287948604172287	0.42413940773095	0.0471147890519059
up	FOLR2; CCR2; S100A12; XCL2; XCL1;	GO:0002548~monocyte chemotaxis	5	44	11.3636363636364	0.00024858948854555	0.00596937616000958	0.440749163191275	0.459641964320738	0.295075722903578	0.440749163191275	0.0483512681084946
down	WNT9A; GDNF; SOX2; ISL1; DLX2; PPP1R13L;	GO:0045597~positive regulation of cell differentiation	6	36	16.6666666666667	0.0002492032383885	0.00360065515542329	0.881930260656925	0.946972305876326	0.380533019020292	0.881681057418537	0.0317581514403494
down	FLRT2; NRP2; SLIT3; FLRT3; SEMA3F; SEMA6D;	GO:0050919~negative chemotaxis	6	36	16.6666666666667	0.0002492032383885	0.00360065515542329	0.881930260656925	0.946972305876326	0.380533019020292	0.881681057418537	0.0317581514403494
down	SOX15; INHA; KITLG; WNT5A; SOX9; SFRP1; TFAP2C; SIX4; BOK;	GO:0008584~male gonad development	9	90	10	0.00027045530653202	0.00389291729099127	0.956600419203772	1	0.394932411262576	0.956600419203772	0.0343359337496793
down	IL33; ADORA2B; WNT5A; ISL1; RAB7B; IL1RL2; IL36A;	GO:0032755~positive regulation of interleukin-6 production	7	53	13.2075471698113	0.00027989847764575	0.00397215898449371	0.989441118477751	1	0.401374416944015	0.989441118477751	0.0350348536945259
down	PLPP3; LRP6; FBLN1; BDKRB1; XDH; DAB2IP; CD109; WWTR1;	GO:0001933~negative regulation of protein phosphorylation	8	71	11.2676056338028	0.0002810554276672	0.00397215898449371	0.993249881375918	1	0.402190316991777	0.993249881375918	0.0350348536945259
down	GLI3; VEGFC; CX3CL1; DMRTA2; SMO;	GO:0002052~positive regulation of neuroblast proliferation	5	23	21.7391304347826	0.00028223234889823	0.00397215898449371	0.997126888657471	1	0.403027794226682	0.996562423959675	0.0350348536945259
down	DSCAM; TSPAN12; TFAP2A; LHX1; FJX1;	GO:0010842~retina layer formation	5	23	21.7391304347826	0.00028223234889823	0.00397215898449371	0.997126888657471	1	0.403027794226682	0.996562423959675	0.0350348536945259
down	PTN; MDK; ASPA; IL34; ZNF488;	GO:0048714~positive regulation of oligodendrocyte differentiation	5	23	21.7391304347826	0.00028223234889823	0.00397215898449371	0.997126888657471	1	0.403027794226682	0.996562423959675	0.0350348536945259
down	NFIB; BMP4; SOX9; HMGA2; OSR1; WNT5B;	GO:0002062~chondrocyte differentiation	6	37	16.2162162162162	0.00028443416106249	0.00398837569017523	1	1	0.40446537703087	0.999148947208221	0.0351778867184248
up	PF4; CXCR5; CNR2; PF4V1;	GO:0030595~leukocyte chemotaxis	4	24	16.6666666666667	0.00028477820887618	0.00665212120132873	0.50462698612859	0.526554908212056	0.322084154238959	0.504342207919714	0.053881425307118
up	PF4; IRF8; IRF4; BATF;	GO:0042832~defense response to protozoan	4	24	16.6666666666667	0.00028477820887618	0.00665212120132873	0.50462698612859	0.526554908212056	0.322084154238959	0.504342207919714	0.053881425307118
up	MS4A1; PTPN2; CD40LG; FLT3; HHEX; CD79B;	GO:0030183~B cell differentiation	6	72	8.33333333333333	0.00028781487079843	0.00665212120132873	0.509432321313222	0.532169696106298	0.324367359389831	0.509432321313222	0.053881425307118
down	DLL1; BMP4; WNT5A; SMO;	GO:0003323~type B pancreatic cell development	4	12	33.3333333333333	0.00030196846998686	0.00417265522163673	1	1	0.416414520111892	0.999148947208221	0.036803251274288
down	F3; ITGA2; KDR; CDH13;	GO:0050927~positive regulation of positive chemotaxis	4	12	33.3333333333333	0.00030196846998686	0.00417265522163673	1	1	0.416414520111892	0.999148947208221	0.036803251274288
down	TERT; TBX3; GJA1; HMGA2;	GO:2000648~positive regulation of stem cell proliferation	4	12	33.3333333333333	0.00030196846998686	0.00417265522163673	1	1	0.416414520111892	0.999148947208221	0.036803251274288
up	SPI1; CEBPE; NKAP;	GO:0030851~granulocyte differentiation	3	9	33.3333333333333	0.00030809406504728	0.00694714544234664	0.545018401068642	0.569665926272424	0.335822530901537	0.544710307003594	0.0562710881116712
up	LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.00030809406504728	0.00694714544234664	0.545018401068642	0.569665926272424	0.335822530901537	0.544710307003594	0.0562710881116712
down	JUP; PKP2; PKP3;	GO:0002159~desmosome assembly	3	4	75	0.00031495485423893	0.004259175964797	1	1	0.424244188659846	0.999148947208221	0.0375663731911082
down	MSX1; PAX9; SP6;	GO:0042481~regulation of odontogenesis	3	4	75	0.00031495485423893	0.004259175964797	1	1	0.424244188659846	0.999148947208221	0.0375663731911082
down	HOXA5; JAG1; CSF3;	GO:0045639~positive regulation of myeloid cell differentiation	3	4	75	0.00031495485423893	0.004259175964797	1	1	0.424244188659846	0.999148947208221	0.0375663731911082
down	HOXA5; WNT7B; LRP6;	GO:0060535~trachea cartilage morphogenesis	3	4	75	0.00031495485423893	0.004259175964797	1	1	0.424244188659846	0.999148947208221	0.0375663731911082
down	GDNF; SIX1; SIX4;	GO:0072107~positive regulation of ureteric bud formation	3	4	75	0.00031495485423893	0.004259175964797	1	1	0.424244188659846	0.999148947208221	0.0375663731911082
down	BMP4; SOX9; FOXD1;	GO:0090184~positive regulation of kidney development	3	4	75	0.00031495485423893	0.004259175964797	1	1	0.424244188659846	0.999148947208221	0.0375663731911082
up	CD40LG; XCL1; TIGIT; IL23A;	GO:0032733~positive regulation of interleukin-10 production	4	25	16	0.00032734904914155	0.00729239026340648	0.57842576983313	0.605268391862738	0.346335293991767	0.57842576983313	0.0590675319038994
down	MEIS2; ISL1; NKX3-2; HES1; PROX1;	GO:0031016~pancreas development	5	24	20.8333333333333	0.00033508209538213	0.00449933555636787	1	1	0.433701246303909	0.999148947208221	0.0396846056654046
down	TBX1; WNT5A; SOX9; SIX1; VANGL2;	GO:0090103~cochlea morphogenesis	5	24	20.8333333333333	0.00033508209538213	0.00449933555636787	1	1	0.433701246303909	0.999148947208221	0.0396846056654046
up	CD40LG; IRF8; SCIMP; IL23A;	GO:0032735~positive regulation of interleukin-12 production	4	26	15.3846153846154	0.00037428885421109	0.00823881061233699	0.660994116536787	0.692060091436308	0.371668832231614	0.660994116536787	0.0667334291112218
down	MCAM; TBC1D8B; SULF1; ADGRF5;	GO:0003094~glomerular filtration	4	13	30.7692307692308	0.00038824212146382	0.00512263910264765	1	1	0.456338107029912	0.999148947208221	0.0451822075077374
down	BMP4; ISL1; JAG1; PPP1R13L;	GO:0003215~cardiac right ventricle morphogenesis	4	13	30.7692307692308	0.00038824212146382	0.00512263910264765	1	1	0.456338107029912	0.999148947208221	0.0451822075077374
down	ITGA2; CPS1; PROX1; ANXA1;	GO:0070365~hepatocyte differentiation	4	13	30.7692307692308	0.00038824212146382	0.00512263910264765	1	1	0.456338107029912	0.999148947208221	0.0451822075077374
down	HES1; PARD3; FERMT1; FRMD4A;	GO:0090162~establishment of epithelial cell polarity	4	13	30.7692307692308	0.00038824212146382	0.00512263910264765	1	1	0.456338107029912	0.999148947208221	0.0451822075077374
down	MELTF; FBLN1; KANK1; POSTN;	GO:1900025~negative regulation of substrate adhesion-dependent cell spreading	4	13	30.7692307692308	0.00038824212146382	0.00512263910264765	1	1	0.456338107029912	0.999148947208221	0.0451822075077374
down	PYCR1; ASPA; FOLH1; ASPG; GPT2;	GO:0008652~cellular amino acid biosynthetic process	5	25	20	0.00039508850256753	0.00517702175778144	1	1	0.459253955012554	0.999148947208221	0.0456618681591791
down	KRT16; FLG; SFN; KDF1; TP63;	GO:0061436~establishment of skin barrier	5	25	20	0.00039508850256753	0.00517702175778144	1	1	0.459253955012554	0.999148947208221	0.0456618681591791
up	IL2RA; FCER2; FOXC1; NRARP; NKAP; PERP; CHAC1;	GO:0007219~Notch signaling pathway	7	109	6.42201834862385	0.0004073274345544	0.00875753984291971	0.718932921988525	0.753148426491095	0.388590372564903	0.718525594553971	0.0709350768933877
up	LILRA5; ADRB2; OSM; FLT4; FLT3; WWC1; FCRL3;	GO:0043410~positive regulation of MAPK cascade	7	109	6.42201834862385	0.0004073274345544	0.00875753984291971	0.718932921988525	0.753148426491095	0.388590372564903	0.718525594553971	0.0709350768933877
down	ITGB4; ITGA2; ITGB5; VCAM1; EMP2; FERMT2; MUC4; COL17A1; ITGB6;	GO:0007160~cell-matrix adhesion	9	96	9.375	0.00041938372287364	0.00547648847738781	1	1	0.469676931895751	0.999148947208221	0.0483031956460057
up	C1QA; AIF1; TLR8; TLR7;	GO:0001774~microglial cell activation	4	27	14.8148148148148	0.00042584768971387	0.00905048710667767	0.750769476965564	0.787392378280957	0.397315894503047	0.750769476965564	0.0733079164183119
down	COL5A2; MGP; BMP7; SOX9; STC1; CDH11; ECM1; FOXC2;	GO:0001503~ossification	8	76	10.5263157894737	0.00042791576634426	0.0055687668222884	1	1	0.473274837576759	0.999148947208221	0.0491171002065699
down	GABRP; SLC1A3; SLC1A1; FXYD3; CLCA4; ANO4; ANO1; GABRQ; CLCA2;	GO:1902476~chloride transmembrane transport	9	97	9.27835051546392	0.00044976032285359	0.00583306903359616	1	1	0.481755961430296	0.999148947208221	0.0514482730877297
down	BMP7; WNT5A; SOX9; PRRX1; PITX1; DLX2; SULF1;	GO:0051216~cartilage development	7	58	12.0689655172414	0.00046030365255456	0.00593249250946452	1	1	0.485620353445062	0.999148947208221	0.0523251984435493
down	BAG3; DAB2IP; TM7SF3; HSPB8; HSPA1B;	GO:0034620~cellular response to unfolded protein	5	26	19.2307692307692	0.00046285922372946	0.00593249250946452	1	1	0.486465044139664	0.999148947208221	0.0523251984435493
down	EPHA3; ARHGEF5; DLC1; VANGL2; FZD10; BAIAP2; ARHGAP40; RHOD;	GO:0032956~regulation of actin cytoskeleton organization	8	77	10.3896103896104	0.00046367112508183	0.00593249250946452	1	1	0.486854681335924	0.999148947208221	0.0523251984435493
down	APOE; GPX3; NXN; TXNRD3; GPX8; CYGB; PXDN; DUOX1;	GO:0098869~cellular oxidant detoxification	8	77	10.3896103896104	0.00046367112508183	0.00593249250946452	1	1	0.486854681335924	0.999148947208221	0.0523251984435493
up	HBA1; HBG2; HBM; HBG1;	GO:0042744~hydrogen peroxide catabolic process	4	28	14.2857142857143	0.00048227781411847	0.0101333145261938	0.849773508476745	0.891731678305052	0.422957642981898	0.849773508476745	0.0820786953863051
down	WNT5A; TP63; INTU; VANGL2;	GO:0001736~establishment of planar polarity	4	14	28.5714285714286	0.00049078144529246	0.00607930353702353	1	1	0.496516045829862	0.999148947208221	0.0536200869138627
down	HOXA5; CCBE1; NDN; JAG2;	GO:0003016~respiratory system process	4	14	28.5714285714286	0.00049078144529246	0.00607930353702353	1	1	0.496516045829862	0.999148947208221	0.0536200869138627
down	TBX1; JAG1; TBX2; SIX1;	GO:0035909~aorta morphogenesis	4	14	28.5714285714286	0.00049078144529246	0.00607930353702353	1	1	0.496516045829862	0.999148947208221	0.0536200869138627
down	MEIS2; EPHA2; P2RY1; SOX2;	GO:0070848~response to growth factor	4	14	28.5714285714286	0.00049078144529246	0.00607930353702353	1	1	0.496516045829862	0.999148947208221	0.0536200869138627
down	COBL; BMP7; PTN; DAB2IP;	GO:1900006~positive regulation of dendrite development	4	14	28.5714285714286	0.00049078144529246	0.00607930353702353	1	1	0.496516045829862	0.999148947208221	0.0536200869138627
down	LOX; LOXL2; LOXL1;	GO:0018057~peptidyl-lysine oxidation	3	5	60	0.00049594318328349	0.00607930353702353	1	1	0.498416378179914	0.999148947208221	0.0536200869138627
down	TBX1; HOXC13; INTU;	GO:0043587~tongue morphogenesis	3	5	60	0.00049594318328349	0.00607930353702353	1	1	0.498416378179914	0.999148947208221	0.0536200869138627
down	HMGB3; INHA; SFRP1;	GO:0045578~negative regulation of B cell differentiation	3	5	60	0.00049594318328349	0.00607930353702353	1	1	0.498416378179914	0.999148947208221	0.0536200869138627
down	LRP4; SHANK2; SHANK3;	GO:0051124~synaptic growth at neuromuscular junction	3	5	60	0.00049594318328349	0.00607930353702353	1	1	0.498416378179914	0.999148947208221	0.0536200869138627
down	NRP2; SIX1; SIX4;	GO:0061551~trigeminal ganglion development	3	5	60	0.00049594318328349	0.00607930353702353	1	1	0.498416378179914	0.999148947208221	0.0536200869138627
down	CAV2; EMP2; CAV1;	GO:0070836~caveola assembly	3	5	60	0.00049594318328349	0.00607930353702353	1	1	0.498416378179914	0.999148947208221	0.0536200869138627
down	LMNA; PTN; WNT5A;	GO:0072201~negative regulation of mesenchymal cell proliferation	3	5	60	0.00049594318328349	0.00607930353702353	1	1	0.498416378179914	0.999148947208221	0.0536200869138627
down	LDLR; CRYAB; APOE;	GO:1905907~negative regulation of amyloid fibril formation	3	5	60	0.00049594318328349	0.00607930353702353	1	1	0.498416378179914	0.999148947208221	0.0536200869138627
up	EREG; FST; SDR16C5;	GO:0043616~keratinocyte proliferation	3	11	27.2727272727273	0.00050108637481682	0.0104102101914193	0.882413106052434	0.926508707036315	0.431435368717289	0.882413106052434	0.0843215187883701
down	SPINT1; FZD6; COBL; BMP4; SHROOM3; DLC1; VANGL2; LRP6;	GO:0001843~neural tube closure	8	78	10.2564102564103	0.0005018106429242	0.00613144837013498	1	1	0.500305210995433	0.999148947208221	0.0540800097432653
down	FHL2; DHCR24; STEAP2; MMP19; FOXC2; NOS1;	GO:0009725~response to hormone	6	42	14.2857142857143	0.00052319102085118	0.0063316110803647	1	1	0.506919252923867	0.999148947208221	0.055845465581104
down	FOSL1; PTN; GJB2; YAP1; CAV1; DSG2;	GO:0032570~response to progesterone	6	42	14.2857142857143	0.00052319102085118	0.0063316110803647	1	1	0.506919252923867	0.999148947208221	0.055845465581104
down	NFASC; ERBB2; ARTN; NTF4; GDNF;	GO:0007422~peripheral nervous system development	5	27	18.5185185185185	0.00053902089406998	0.00646144920336261	1	1	0.511530828472417	0.999148947208221	0.0569906512750708
down	ANXA1; IVL; FLG; SPRR1B; SPRR2E;	GO:0018149~peptide cross-linking	5	27	18.5185185185185	0.00053902089406998	0.00646144920336261	1	1	0.511530828472417	0.999148947208221	0.0569906512750708
down	TBX1; CPS1; LHX1; POSTN; SFRP1;	GO:0044344~cellular response to fibroblast growth factor stimulus	5	27	18.5185185185185	0.00053902089406998	0.00646144920336261	1	1	0.511530828472417	0.999148947208221	0.0569906512750708
up	XCL1; IL23A; CD1C; CD1A;	GO:0001916~positive regulation of T cell mediated cytotoxicity	4	29	13.7931034482759	0.00054383335497798	0.011049976630267	0.957146704761254	1	0.449206351211816	0.956602871406276	0.0895035541941423
up	ORM1; BPI; NCKAP1L; SLAMF1;	GO:0032715~negative regulation of interleukin-6 production	4	29	13.7931034482759	0.00054383335497798	0.011049976630267	0.957146704761254	1	0.449206351211816	0.956602871406276	0.0895035541941423
up	SCEL; GJB5; FABP5; CERS3; GRHL3; GRHL1;	GO:0008544~epidermis development	6	82	7.31707317073171	0.00055132494419452	0.0110804328458225	0.969229251893966	1	0.452254119277676	0.969229251893966	0.0897502460769155
down	SNAI2; ERBB2; SOX9; DAB2IP; GAREM1; BAIAP2;	GO:0071364~cellular response to epidermal growth factor stimulus	6	43	13.953488372093	0.00058555777315572	0.00699723125154634	1	1	0.525646137007574	0.999148947208221	0.0617163044383877
down	DLL1; LAMB2; ROR1; LAMC3;	GO:0014002~astrocyte development	4	15	26.6666666666667	0.00061121927670848	0.00719081502009983	1	1	0.533346791104834	0.999148947208221	0.0634237333291704
down	BMP7; FOXF2; TBX2; LRP6;	GO:0048596~embryonic camera-type eye morphogenesis	4	15	26.6666666666667	0.00061121927670848	0.00719081502009983	1	1	0.533346791104834	0.999148947208221	0.0634237333291704
down	SERPINB5; HES1; SIX1; SIX4;	GO:0050678~regulation of epithelial cell proliferation	4	15	26.6666666666667	0.00061121927670848	0.00719081502009983	1	1	0.533346791104834	0.999148947208221	0.0634237333291704
down	APOE; SH3D19; SNX33; PACSIN3;	GO:0051044~positive regulation of membrane protein ectodomain proteolysis	4	15	26.6666666666667	0.00061121927670848	0.00719081502009983	1	1	0.533346791104834	0.999148947208221	0.0634237333291704
down	GLI3; MYH14; SHANK3; SHANK2;	GO:0071625~vocalization behavior	4	15	26.6666666666667	0.00061121927670848	0.00719081502009983	1	1	0.533346791104834	0.999148947208221	0.0634237333291704
down	TFPI; SOX9; DAB2IP; SFRP1; HAS2; ADAMTS7; CCL26; CX3CL1;	GO:0071347~cellular response to interleukin-1	8	81	9.87654320987654	0.00063171635447956	0.00740901897229115	1	1	0.539485766725545	0.999148947208221	0.0653483147898907
down	PTN; FGFR2; LOX; LGR4; ASPN; TUFT1;	GO:0030282~bone mineralization	6	44	13.6363636363636	0.00065354031372144	0.00754848994571883	1	1	0.546064529299553	0.999148947208221	0.0665784632224551
down	LRP5; AREG; IGFBP5; VEGFC; SFRP1; TWIST2;	GO:0045668~negative regulation of osteoblast differentiation	6	44	13.6363636363636	0.00065354031372144	0.00754848994571883	1	1	0.546064529299553	0.999148947208221	0.0665784632224551
down	WNT9A; HOXA5; SIX1; MDFI; HOXA4; HOXC9;	GO:0048704~embryonic skeletal system morphogenesis	6	44	13.6363636363636	0.00065354031372144	0.00754848994571883	1	1	0.546064529299553	0.999148947208221	0.0665784632224551
down	FOSL1; AREG; SDC1; ALDH3A1; MMP19; DUOX1;	GO:0051591~response to cAMP	6	44	13.6363636363636	0.00065354031372144	0.00754848994571883	1	1	0.546064529299553	0.999148947208221	0.0665784632224551
down	KLK8; ITGB4; MDK; SLC1A3; SOX2; DST; TMPRSS4;	GO:0009611~response to wounding	7	62	11.2903225806452	0.00066291233249948	0.00761047390784911	1	1	0.548891411309576	0.999148947208221	0.0671251681889781
down	TPBG; NTRK2; DLG5; SLITRK6; ADGRL3; FLRT3; FLRT2;	GO:0051965~positive regulation of synapse assembly	7	62	11.2903225806452	0.00066291233249948	0.00761047390784911	1	1	0.548891411309576	0.999148947208221	0.0671251681889781
up	RNASE2; DEFA3; LILRB1; RNASE6; NT5C3A; IL23A; TLR8; TLR7; POLR3K;	GO:0051607~defense response to virus	9	198	4.54545454545455	0.00071839535621587	0.0139999426930427	1	1	0.508960025738365	0.982323498149493	0.113397943857132
down	FGFR2; MSX1; HES1; DLG5; LRP6;	GO:0030901~midbrain development	5	29	17.2413793103448	0.00071911152800496	0.00801767654994539	1	1	0.565887283504958	0.999148947208221	0.0707167376718612
down	ERBB2; GLI3; NTRK2; BOK; SOX9;	GO:0048709~oligodendrocyte differentiation	5	29	17.2413793103448	0.00071911152800496	0.00801767654994539	1	1	0.565887283504958	0.999148947208221	0.0707167376718612
down	GPC4; APOE; RBP1; SDC1; GPC1; ADH7; GPC6;	GO:0001523~retinoid metabolic process	7	63	11.1111111111111	0.00072320379293566	0.00801767654994539	1	1	0.566991773661563	0.999148947208221	0.0707167376718612
down	RHOD; MYO1B; SHROOM2; BAIAP2; BAIAP2L1; BAIAP2L2;	GO:0051017~actin filament bundle assembly	6	45	13.3333333333333	0.00072747625184788	0.00801767654994539	1	1	0.568158952693195	0.999148947208221	0.0707167376718612
down	YAP1; WWTR1; NOX4;	GO:0003015~heart process	3	6	50	0.0007321404639029	0.00801767654994539	1	1	0.569605280916463	0.999148947208221	0.0707167376718612
down	PTPRF; PTN; PTPRU;	GO:0007185~transmembrane receptor protein tyrosine phosphatase signaling pathway	3	6	50	0.0007321404639029	0.00801767654994539	1	1	0.569605280916463	0.999148947208221	0.0707167376718612
down	EFNB2; CCBE1; PROX1;	GO:0048845~venous blood vessel morphogenesis	3	6	50	0.0007321404639029	0.00801767654994539	1	1	0.569605280916463	0.999148947208221	0.0707167376718612
down	IGFBP5; ELF3; CAV1;	GO:0060056~mammary gland involution	3	6	50	0.0007321404639029	0.00801767654994539	1	1	0.569605280916463	0.999148947208221	0.0707167376718612
down	BMP4; BMP7; SFRP1;	GO:0060687~regulation of branching involved in prostate gland morphogenesis	3	6	50	0.0007321404639029	0.00801767654994539	1	1	0.569605280916463	0.999148947208221	0.0707167376718612
down	LRP5; COL4A1; LAMA1;	GO:0061304~retinal blood vessel morphogenesis	3	6	50	0.0007321404639029	0.00801767654994539	1	1	0.569605280916463	0.999148947208221	0.0707167376718612
down	BMP4; MSX1; MSX2;	GO:0061312~BMP signaling pathway involved in heart development	3	6	50	0.0007321404639029	0.00801767654994539	1	1	0.569605280916463	0.999148947208221	0.0707167376718612
down	JUP; DSG2; PKP2;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	3	6	50	0.0007321404639029	0.00801767654994539	1	1	0.569605280916463	0.999148947208221	0.0707167376718612
down	MYO1C; CCBE1; ROBO1;	GO:1900748~positive regulation of vascular endothelial growth factor signaling pathway	3	6	50	0.0007321404639029	0.00801767654994539	1	1	0.569605280916463	0.999148947208221	0.0707167376718612
down	GPC6; GPC1; GPC4;	GO:1905475~regulation of protein localization to membrane	3	6	50	0.0007321404639029	0.00801767654994539	1	1	0.569605280916463	0.999148947208221	0.0707167376718612
down	PTPRG; MCC; DAB2IP; MARVELD3;	GO:0010633~negative regulation of epithelial cell migration	4	16	25	0.00075120625047098	0.00810961293122082	1	1	0.575423987860772	0.999148947208221	0.0715276260778296
down	EDN2; EDNRA; BDKRB2; CAV1;	GO:0042310~vasoconstriction	4	16	25	0.00075120625047098	0.00810961293122082	1	1	0.575423987860772	0.999148947208221	0.0715276260778296
down	PTN; MDK; HAS2; ANXA1;	GO:0044849~estrous cycle	4	16	25	0.00075120625047098	0.00810961293122082	1	1	0.575423987860772	0.999148947208221	0.0715276260778296
down	AREG; HOXA5; CCND1; DDR1;	GO:0060749~mammary gland alveolus development	4	16	25	0.00075120625047098	0.00810961293122082	1	1	0.575423987860772	0.999148947208221	0.0715276260778296
down	DSCAM; VSTM2L; PALLD; IGSF9;	GO:0070593~dendrite self-avoidance	4	16	25	0.00075120625047098	0.00810961293122082	1	1	0.575423987860772	0.999148947208221	0.0715276260778296
up	JCHAIN; IGKV3-20; IGHA2;	GO:0003094~glomerular filtration	3	13	23.0769230769231	0.00075780673103731	0.0139999426930427	1	1	0.519481158794299	0.982323498149493	0.113397943857132
up	CD19; FCGR2B; TLR8;	GO:0016064~immunoglobulin mediated immune response	3	13	23.0769230769231	0.00075780673103731	0.0139999426930427	1	1	0.519481158794299	0.982323498149493	0.113397943857132
up	FLT4; FLT3; FOXC1;	GO:0038084~vascular endothelial growth factor signaling pathway	3	13	23.0769230769231	0.00075780673103731	0.0139999426930427	1	1	0.519481158794299	0.982323498149493	0.113397943857132
up	CCR2; SPINK5; TBX21;	GO:0045580~regulation of T cell differentiation	3	13	23.0769230769231	0.00075780673103731	0.0139999426930427	1	1	0.519481158794299	0.982323498149493	0.113397943857132
up	LTF; MS4A1; CCR2; CCR6; JCHAIN;	GO:0006959~humoral immune response	5	58	8.62068965517241	0.00080303097881273	0.0142769642290841	1	1	0.531606507974031	0.982323498149493	0.115641786798493
down	TBX3; TBX1; ISL1; TBX2; HES1; SIX1;	GO:0003151~outflow tract morphogenesis	6	46	13.0434782608696	0.00080771210710117	0.00859749581788368	1	1	0.592378973918034	0.999148947208221	0.0758308036749556
down	BMP7; IGSF9; BAIAP2; LAMC2; EGFLAM; NTN1;	GO:0016358~dendrite development	6	46	13.0434782608696	0.00080771210710117	0.00859749581788368	1	1	0.592378973918034	0.999148947208221	0.0758308036749556
down	DLL1; CXCL14; GJB2; SOX2; ROR1; SIX1;	GO:0048839~inner ear development	6	46	13.0434782608696	0.00080771210710117	0.00859749581788368	1	1	0.592378973918034	0.999148947208221	0.0758308036749556
down	ERBB2; LHX1; LAMC2; NTN1; EGFLAM;	GO:0008045~motor neuron axon guidance	5	30	16.6666666666667	0.00082437807330482	0.00871948142426261	1	1	0.597535375389501	0.999148947208221	0.0769067293589495
down	GJA1; HRH1; CAV1; ADRA1B; ADRA1D;	GO:0045907~positive regulation of vasoconstriction	5	30	16.6666666666667	0.00082437807330482	0.00871948142426261	1	1	0.597535375389501	0.999148947208221	0.0769067293589495
up	GPR55; GPR174; GPR65; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	4	33	12.1212121212121	0.00084644046873971	0.0149054135876166	1	1	0.543204636553348	0.982323498149493	0.120732155140595
down	VCAM1; CXADR; CADM1; TENM2; TENM3; HMCN1;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	6	47	12.7659574468085	0.00089460302258692	0.00941687392196764	1	1	0.614878743859697	0.999148947208221	0.0830578034272676
down	FOSL1; HPGD; ITGA2; IGFBP2; ENDOU; IGFBP5; TEAD3; TFCP2L1;	GO:0007565~female pregnancy	8	86	9.30232558139535	0.00090744212264781	0.00952509923338046	1	1	0.617968085523163	0.999148947208221	0.0840123618843168
up	P2RY10; GPR171; P2RY13;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	3	14	21.4285714285714	0.00091235154954905	0.0157657758422074	1	1	0.560732307914903	0.982323498149493	0.127700991569574
down	PLAU; P2RY1; PCSK9; MUC4;	GO:0010469~regulation of signaling receptor activity	4	17	23.5294117647059	0.00091240424235539	0.00952509923338046	1	1	0.619191646234778	0.999148947208221	0.0840123618843168
down	BMP4; MDK; WNT5A; SOX9;	GO:0061036~positive regulation of cartilage development	4	17	23.5294117647059	0.00091240424235539	0.00952509923338046	1	1	0.619191646234778	0.999148947208221	0.0840123618843168
down	EML1; KRT75; BMP4; DACT2; SFRP1; BVES; PYGO1;	GO:0002244~hematopoietic progenitor cell differentiation	7	66	10.6060606060606	0.00093045597956797	0.00968693896536526	1	1	0.623405506310546	0.999148947208221	0.0854398050843959
up	CD3D; PTPN2; TBX21; CD3G;	GO:0030217~T cell differentiation	4	34	11.7647058823529	0.00093747917571374	0.0160499907027288	1	1	0.566941431076525	0.982323498149493	0.130003099621257
down	S100A2; PRSS3; CDH13; LOXL2; TGFB1I1;	GO:0043542~endothelial cell migration	5	31	16.1290322580645	0.00094070828990711	0.00976691667116672	1	1	0.625740868359901	0.999148947208221	0.0861452167339589
down	PLXNB1; DCN; CSF3; KDR; SOX9; NTRK2; UNC5B; ROR1;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	8	87	9.19540229885057	0.00097268287065499	0.0100713757724495	1	1	0.633252747231127	0.999148947208221	0.0888305775443016
down	BMP4; FGFR2; LHX1; PPP1R13L; NDN; ETNK2; DHCR7;	GO:0009791~post-embryonic development	7	67	10.4477611940298	0.00100904718038453	0.0103209482203524	1	1	0.639735912363789	0.999148947208221	0.0910318323864659
down	BMP4; EPHA2; SEMA5A;	GO:0002043~blood vessel endothelial cell proliferation involved in sprouting angiogenesis	3	7	42.8571428571429	0.00102937878302989	0.0103209482203524	1	1	0.643021983075321	0.999148947208221	0.0910318323864659
down	ITGA2; VEGFC; CSPG4;	GO:0006929~substrate-dependent cell migration	3	7	42.8571428571429	0.00102937878302989	0.0103209482203524	1	1	0.643021983075321	0.999148947208221	0.0910318323864659
down	TBX3; HOXD8; WNT5A;	GO:0008595~anterior/posterior axis specification, embryo	3	7	42.8571428571429	0.00102937878302989	0.0103209482203524	1	1	0.643021983075321	0.999148947208221	0.0910318323864659
down	PLAU; DDR1; PLAT;	GO:0014909~smooth muscle cell migration	3	7	42.8571428571429	0.00102937878302989	0.0103209482203524	1	1	0.643021983075321	0.999148947208221	0.0910318323864659
down	IGSF3; FGFR2; SOX9;	GO:0032808~lacrimal gland development	3	7	42.8571428571429	0.00102937878302989	0.0103209482203524	1	1	0.643021983075321	0.999148947208221	0.0910318323864659
down	LHX1; PROX1; LRP6;	GO:0060059~embryonic retina morphogenesis in camera-type eye	3	7	42.8571428571429	0.00102937878302989	0.0103209482203524	1	1	0.643021983075321	0.999148947208221	0.0910318323864659
down	YAP1; SOX9; FOXA1;	GO:0060487~lung epithelial cell differentiation	3	7	42.8571428571429	0.00102937878302989	0.0103209482203524	1	1	0.643021983075321	0.999148947208221	0.0910318323864659
down	IL33; CX3CL1; IL34;	GO:0061518~microglial cell proliferation	3	7	42.8571428571429	0.00102937878302989	0.0103209482203524	1	1	0.643021983075321	0.999148947208221	0.0910318323864659
down	BCAR3; EDNRA; BCAR1;	GO:0086100~endothelin receptor signaling pathway	3	7	42.8571428571429	0.00102937878302989	0.0103209482203524	1	1	0.643021983075321	0.999148947208221	0.0910318323864659
down	LHX1; OSR1; FOXA2;	GO:2000543~positive regulation of gastrulation	3	7	42.8571428571429	0.00102937878302989	0.0103209482203524	1	1	0.643021983075321	0.999148947208221	0.0910318323864659
up	CD300LF; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	4	35	11.4285714285714	0.00103519059111545	0.0174006127542952	1	1	0.586648631008342	0.982323498149493	0.14094298465749
up	LTF; DEFA4; DEFA3; S100A12;	GO:0031640~killing of cells of other organism	4	35	11.4285714285714	0.00103519059111545	0.0174006127542952	1	1	0.586648631008342	0.982323498149493	0.14094298465749
down	SPRY2; CSF3; NOS1; WNT5A; CAV1; NTRK2; TNKS1BP1; BCAR3;	GO:0033138~positive regulation of peptidyl-serine phosphorylation	8	88	9.09090909090909	0.00104162236287253	0.0104162236287253	1	1	0.644856776655037	0.999148947208221	0.0918721713573026
down	LRP4; NR2F2; KREMEN2; INTU; ZNRF3;	GO:0060173~limb development	5	32	15.625	0.00106880581016577	0.0106600054557216	1	1	0.64942850501726	0.999148947208221	0.0940223523232563
up	ELANE; KEL; CCR2; RYR2; ATP13A4; ATP2C2;	GO:0006874~cellular calcium ion homeostasis	6	94	6.38297872340426	0.00108025280029822	0.0179203875225054	1	1	0.594435840597183	0.982323498149493	0.145153101175549
up	ELANE; TLR8; TLR7;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	3	15	20	0.00108549670228264	0.0179203875225054	1	1	0.59533904788463	0.982323498149493	0.145153101175549
down	DLL1; LAMA5; FUT1; LAMA1; SOX9; JAG2;	GO:0030155~regulation of cell adhesion	6	49	12.2448979591837	0.00108981190138446	0.0108410607991125	1	1	0.652797328929293	0.999148947208221	0.0956192792063626
up	TRAV27; RNASE2; RNASE3; DEFA4; DEFA3; RNASE6;	GO:0050830~defense response to Gram-positive bacterium	6	95	6.31578947368421	0.00113747911665296	0.0186123795282418	1	1	0.603908502392366	0.982323498149493	0.150758157734465
up	ASS1; FASLG; AIF1; IRF8; XCL1; XCL2;	GO:0071346~cellular response to interferon-gamma	6	96	6.25	0.00119699854916611	0.0190799193954059	1	1	0.613356875311151	0.982323498149493	0.154545177493767
down	AREG; SOX9; BCAR1; EFEMP1; FAM83A; GAREM1;	GO:0007173~epidermal growth factor receptor signaling pathway	6	50	12	0.00119888048329198	0.0118639214492435	1	1	0.670004566972364	0.999148947208221	0.104641016092304
down	MYO1D; DLG2; SH3RF2; CSRNP3; PKMYT1; CAMSAP3;	GO:0010923~negative regulation of phosphatase activity	6	50	12	0.00119888048329198	0.0118639214492435	1	1	0.670004566972364	0.999148947208221	0.104641016092304
down	NGFR; NTRK2; ROBO1; PLXNA2; PLXNB1;	GO:0050772~positive regulation of axonogenesis	5	33	15.1515151515152	0.00120938596566034	0.0119058722008012	1	1	0.671261327366845	0.999148947208221	0.105011026066461
down	EYA2; BAG3; KITLG; BCL2L10; BOK;	GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand	5	33	15.1515151515152	0.00120938596566034	0.0119058722008012	1	1	0.671261327366845	0.999148947208221	0.105011026066461
up	LILRA5; AIF1; LILRA2; TLR8;	GO:2000778~positive regulation of interleukin-6 secretion	4	37	10.8108108108108	0.0012516675088271	0.0190799193954059	1	1	0.62207875188707	0.982323498149493	0.154545177493767
up	CCR2; XCL1; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	3	16	18.75	0.00127805445323814	0.0190799193954059	1	1	0.626308900193742	0.982323498149493	0.154545177493767
up	TRIM16; FOXC1; OVOL2;	GO:0045618~positive regulation of keratinocyte differentiation	3	16	18.75	0.00127805445323814	0.0190799193954059	1	1	0.626308900193742	0.982323498149493	0.154545177493767
down	EPHA2; WNT5A; TP63; VANGL2;	GO:0036342~post-anal tail morphogenesis	4	19	21.0526315789474	0.00130510071160339	0.0127163659079305	1	1	0.68517787359178	0.999148947208221	0.112159664517352
down	APOE; NOS1; BDKRB2; CPS1;	GO:0042311~vasodilation	4	19	21.0526315789474	0.00130510071160339	0.0127163659079305	1	1	0.68517787359178	0.999148947208221	0.112159664517352
down	NOS1; ADRA1B; RNF207; EHD3;	GO:0055117~regulation of cardiac muscle contraction	4	19	21.0526315789474	0.00130510071160339	0.0127163659079305	1	1	0.68517787359178	0.999148947208221	0.112159664517352
down	ADCY6; NPR1; P2RY1; FOXC2;	GO:0097746~regulation of blood vessel diameter	4	19	21.0526315789474	0.00130510071160339	0.0127163659079305	1	1	0.68517787359178	0.999148947208221	0.112159664517352
down	LRP4; CSF3; GHR; AREG; EFNA1; KITLG; CNTN1; CSPG4;	GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation	8	92	8.69565217391304	0.00135740192126188	0.0128797125955615	1	1	0.692374162890052	0.999148947208221	0.113600399222327
down	GJB3; COL5A2; DHCR24; DACT2; FRAS1;	GO:0043588~skin development	5	34	14.7058823529412	0.00136317453563883	0.0128797125955615	1	1	0.693362215398701	0.999148947208221	0.113600399222327
down	TBX3; SLIT3; HES1; PROX1; ROBO1;	GO:0060412~ventricular septum morphogenesis	5	34	14.7058823529412	0.00136317453563883	0.0128797125955615	1	1	0.693362215398701	0.999148947208221	0.113600399222327
up	FST; PTPRZ1; SERPINB12; FLT3; PLD4;	GO:0002244~hematopoietic progenitor cell differentiation	5	66	7.57575757575758	0.00137979490692219	0.0202479427214217	1	1	0.64160463171882	0.982323498149493	0.164006033616641
down	APOE; CDH1; AREG; GDNF; RAB13; CNTN1; NRTN; FLRT3; CAMSAP3;	GO:0031175~neuron projection development	9	115	7.82608695652174	0.00138661900559078	0.0128797125955615	1	1	0.696390986712681	0.999148947208221	0.113600399222327
down	CAV1; ECM1; PXDN;	GO:0001960~negative regulation of cytokine-mediated signaling pathway	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	FGFR2; MSX2; ECM1;	GO:0003416~endochondral bone growth	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	GJA1; GJB2; GJC1;	GO:0016264~gap junction assembly	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	PDLIM1; DST; DLG5;	GO:0030011~maintenance of cell polarity	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	PLPP3; PTPRU; XG;	GO:0034109~homotypic cell-cell adhesion	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	MAOA; MAOB; MOXD1;	GO:0042420~dopamine catabolic process	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	AXL; NHLH2; TYRO3;	GO:0042698~ovulation cycle	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	NGFR; SOX2; TP63;	GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	APOE; PC; CAV2;	GO:0044794~positive regulation by host of viral process	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	BMP4; SFN; KDF1;	GO:0045606~positive regulation of epidermal cell differentiation	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	CHEK1; BMP4; BMP7;	GO:0045839~negative regulation of mitotic nuclear division	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	NRP2; SLIT3; SEMA3F;	GO:0048846~axon extension involved in axon guidance	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	DLL1; LRP5; PROX1;	GO:0060042~retina morphogenesis in camera-type eye	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	TERT; PTN; HES1;	GO:0060253~negative regulation of glial cell proliferation	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	MMP2; MSX2; SFRP1;	GO:0060346~bone trabecula formation	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	BMP4; HES1; ADGRF5;	GO:0061626~pharyngeal arch artery morphogenesis	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	SIX1; OSR1; SIX4;	GO:0072075~metanephric mesenchyme development	3	8	37.5	0.00139304259915152	0.0128797125955615	1	1	0.697422705160274	0.999148947208221	0.113600399222327
down	ZBTB7C; SNAI2; LRP5; SFRP1; CCDC3; WNT5B;	GO:0045600~positive regulation of fat cell differentiation	6	52	11.5384615384615	0.00144187799561646	0.0132988747168508	1	1	0.703858523918347	0.999148947208221	0.117297452550501
up	CD3G; SLA; GRAP; SKAP1; FCRL2;	GO:0009967~positive regulation of signal transduction	5	67	7.46268656716418	0.00146891813156813	0.0213860600414919	1	1	0.653668568547818	0.982323498149493	0.173224654492016
up	GATA1; NCKAP1L; LYAR;	GO:0048821~erythrocyte development	3	17	17.6470588235294	0.00149080160122339	0.0214252601456529	1	1	0.656258737682062	0.982323498149493	0.173542170878212
up	GPR65; P2RY10; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	4	39	10.2564102564103	0.00149793846128177	0.0214252601456529	1	1	0.65755232789017	0.982323498149493	0.173542170878212
down	SPRY2; AREG; PTPN3; DAB2IP; CBLC;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	5	35	14.2857142857143	0.00153090649837206	0.0140137736595744	1	1	0.714876577017812	0.999148947208221	0.123602935277267
down	HOXC11; LAMC1; BMP4; PAX9;	GO:0007492~endoderm development	4	20	20	0.00153992618622112	0.0140137736595744	1	1	0.715882521421079	0.999148947208221	0.123602935277267
down	FGF5; MSX1; MSX2; P2RY1;	GO:0023019~signal transduction involved in regulation of gene expression	4	20	20	0.00153992618622112	0.0140137736595744	1	1	0.715882521421079	0.999148947208221	0.123602935277267
down	DDR1; POSTN; PAK6; FLRT3;	GO:1990138~neuron projection extension	4	20	20	0.00153992618622112	0.0140137736595744	1	1	0.715882521421079	0.999148947208221	0.123602935277267
down	GSTA4; CYP2E1; NQO1; AADAC; ALDH3A1; CYP2J2; FMO1; FMO2;	GO:0006805~xenobiotic metabolic process	8	94	8.51063829787234	0.00154151510255318	0.0140137736595744	1	1	0.715882521421079	0.999148947208221	0.123602935277267
down	HSPA1B; GPX3; GJB2; PYCR1; ETV5; DHRS2; GPX8; NOX4;	GO:0034599~cellular response to oxidative stress	8	94	8.51063829787234	0.00154151510255318	0.0140137736595744	1	1	0.715882521421079	0.999148947208221	0.123602935277267
down	LRP5; CYP7B1; LDLR; APOE; CYP11A1; SREBF2; PCSK9;	GO:0008203~cholesterol metabolic process	7	73	9.58904109589041	0.00159636872235924	0.0144778070285564	1	1	0.722168185858065	0.999148947208221	0.127695757658024
down	EML1; MID1; OBSL1; CRMP1; MARK1; CAMSAP3; PARD3; TUBB6; CALML3;	GO:0000226~microtubule cytoskeleton organization	9	118	7.6271186440678	0.00163738190332352	0.0148144076967366	1	1	0.726997565075643	0.999148947208221	0.130664610417748
up	PF4; ADGRF1; GPR65; ADGRE1; ADGRE3; PTGDR;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	6	103	5.8252427184466	0.00168297739906775	0.0236189938252248	1	1	0.681633007148808	0.982323498149493	0.191311164229679
down	TERT; FGFR2; KANK1; SULF1; SFRP1;	GO:0030177~positive regulation of Wnt signaling pathway	5	36	13.8888888888889	0.00171332478649378	0.0154503064775128	1	1	0.735211075928232	0.999148947208221	0.136273303533001
down	CXCL14; LOX; EPHA2; BCAR1; CX3CL1; SEMA5A; ARHGEF16;	GO:0060326~cell chemotaxis	7	74	9.45945945945946	0.00171579719302906	0.0154503064775128	1	1	0.735717298688303	0.999148947208221	0.136273303533001
up	FUT3; FUT7; SIRPG;	GO:0022409~positive regulation of cell-cell adhesion	3	18	16.6666666666667	0.00172448034959727	0.0236189938252248	1	1	0.68750915376216	0.982323498149493	0.191311164229679
up	KIR3DL1; IL18; RAET1E;	GO:0042267~natural killer cell mediated cytotoxicity	3	18	16.6666666666667	0.00172448034959727	0.0236189938252248	1	1	0.68750915376216	0.982323498149493	0.191311164229679
up	TRPM2; SLC39A8; SLC39A2;	GO:0071577~zinc ion transmembrane transport	3	18	16.6666666666667	0.00172448034959727	0.0236189938252248	1	1	0.68750915376216	0.982323498149493	0.191311164229679
up	RNASE2; RNASE3; RNASE6;	GO:0090501~RNA phosphodiester bond hydrolysis	3	18	16.6666666666667	0.00172448034959727	0.0236189938252248	1	1	0.68750915376216	0.982323498149493	0.191311164229679
down	FMO1; FMO2; CYP2J2; CYP2E1;	GO:0006082~organic acid metabolic process	4	21	19.047619047619	0.00180260646930985	0.0158601312895933	1	1	0.744253982185127	0.999148947208221	0.139888000826759
down	SNAI2; EDNRA; SOX9; FOXC2;	GO:0014032~neural crest cell development	4	21	19.047619047619	0.00180260646930985	0.0158601312895933	1	1	0.744253982185127	0.999148947208221	0.139888000826759
down	FZD6; WNT5A; FZD10; SFRP1;	GO:0035567~non-canonical Wnt signaling pathway	4	21	19.047619047619	0.00180260646930985	0.0158601312895933	1	1	0.744253982185127	0.999148947208221	0.139888000826759
down	KLK8; ETV5; WNT5A; IGSF9;	GO:0050807~regulation of synapse organization	4	21	19.047619047619	0.00180260646930985	0.0158601312895933	1	1	0.744253982185127	0.999148947208221	0.139888000826759
down	LRP5; LRP6; SFN; DAB2IP;	GO:0071901~negative regulation of protein serine/threonine kinase activity	4	21	19.047619047619	0.00180260646930985	0.0158601312895933	1	1	0.744253982185127	0.999148947208221	0.139888000826759
down	ANXA1; KDR; FOXC2; PLK2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	4	21	19.047619047619	0.00180260646930985	0.0158601312895933	1	1	0.744253982185127	0.999148947208221	0.139888000826759
down	SFN; KDF1; PALLD;	GO:0003334~keratinocyte development	3	9	33.3333333333333	0.00182808881706364	0.0158601312895933	1	1	0.746525398774715	0.999148947208221	0.139888000826759
down	COBL; YAP1; SOX9;	GO:0030903~notochord development	3	9	33.3333333333333	0.00182808881706364	0.0158601312895933	1	1	0.746525398774715	0.999148947208221	0.139888000826759
down	KLK8; TNFRSF21; TMEM98;	GO:0031642~negative regulation of myelination	3	9	33.3333333333333	0.00182808881706364	0.0158601312895933	1	1	0.746525398774715	0.999148947208221	0.139888000826759
down	WTIP; DLG5; AJUBA;	GO:0035331~negative regulation of hippo signaling	3	9	33.3333333333333	0.00182808881706364	0.0158601312895933	1	1	0.746525398774715	0.999148947208221	0.139888000826759
down	FUT1; FUT6; FUT10;	GO:0042355~L-fucose catabolic process	3	9	33.3333333333333	0.00182808881706364	0.0158601312895933	1	1	0.746525398774715	0.999148947208221	0.139888000826759
down	LOX; MFAP4; THSD4;	GO:0048251~elastic fiber assembly	3	9	33.3333333333333	0.00182808881706364	0.0158601312895933	1	1	0.746525398774715	0.999148947208221	0.139888000826759
down	BAIAP2; BAIAP2L1; BAIAP2L2;	GO:0051764~actin crosslink formation	3	9	33.3333333333333	0.00182808881706364	0.0158601312895933	1	1	0.746525398774715	0.999148947208221	0.139888000826759
down	PXDN; LAMB2; LAMB3;	GO:0070831~basement membrane assembly	3	9	33.3333333333333	0.00182808881706364	0.0158601312895933	1	1	0.746525398774715	0.999148947208221	0.139888000826759
down	HRAS; GPC4; GPC6;	GO:0098696~regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	3	9	33.3333333333333	0.00182808881706364	0.0158601312895933	1	1	0.746525398774715	0.999148947208221	0.139888000826759
down	FGF1; PTN; MDK;	GO:2000347~positive regulation of hepatocyte proliferation	3	9	33.3333333333333	0.00182808881706364	0.0158601312895933	1	1	0.746525398774715	0.999148947208221	0.139888000826759
up	CA4; HBA1; SLC26A9; SLC39A8;	GO:0015701~bicarbonate transport	4	42	9.52380952380952	0.00192769850084551	0.0249252764200234	1	1	0.714470297046951	0.982323498149493	0.201891904708005
up	EREG; TAL1; CXCR3; FOXC1; IL18; PIK3R6; EPGN; OVOL2; PROK2;	GO:0001525~angiogenesis	9	230	3.91304347826087	0.00194643519530824	0.0249927685842009	1	1	0.716640897565641	0.982323498149493	0.202438583563198
up	HLA-DQA2; HLA-DQB2; IRF8; IRF4; FCGR1B;	GO:0060333~interferon-gamma-mediated signaling pathway	5	72	6.94444444444444	0.00197932169041715	0.0250729359197372	1	1	0.721094371043645	0.982323498149493	0.203087929865082
up	GATA1; TAL1; CLEC1B;	GO:0030220~platelet formation	3	19	15.7894736842105	0.00197979915861635	0.0250729359197372	1	1	0.721094371043645	0.982323498149493	0.203087929865082
down	FOXE1; TBX1; HOXA5; SIX1;	GO:0030878~thyroid gland development	4	22	18.1818181818182	0.00209477603255059	0.0179282633416492	1	1	0.77292747352455	0.999148947208221	0.158129139750853
down	TBX3; ITGA2; SOX9; CAV1;	GO:0030879~mammary gland development	4	22	18.1818181818182	0.00209477603255059	0.0179282633416492	1	1	0.77292747352455	0.999148947208221	0.158129139750853
down	GPR143; SHROOM2; TYRP1; RAB38;	GO:0032438~melanosome organization	4	22	18.1818181818182	0.00209477603255059	0.0179282633416492	1	1	0.77292747352455	0.999148947208221	0.158129139750853
down	APOD; PTN; MDK; SOX2;	GO:0042246~tissue regeneration	4	22	18.1818181818182	0.00209477603255059	0.0179282633416492	1	1	0.77292747352455	0.999148947208221	0.158129139750853
down	KRT16; KRT6C; DST; FAM83H;	GO:0045104~intermediate filament cytoskeleton organization	4	22	18.1818181818182	0.00209477603255059	0.0179282633416492	1	1	0.77292747352455	0.999148947208221	0.158129139750853
down	DLG5; VANGL2; DLG2; PARD3;	GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity	4	22	18.1818181818182	0.00209477603255059	0.0179282633416492	1	1	0.77292747352455	0.999148947208221	0.158129139750853
up	POMC; NMU; NMUR1; PROK2; SSTR3; CYSLTR2;	GO:0007218~neuropeptide signaling pathway	6	108	5.55555555555556	0.00211259173969913	0.0265726675285966	1	1	0.739257154582968	0.982323498149493	0.215235585359895
down	RAB13; MARVELD2; PARD3; MARVELD3; PARD6G;	GO:0070830~bicellular tight junction assembly	5	38	13.1578947368421	0.00212522442990071	0.0181072933489298	1	1	0.775706916913758	0.999148947208221	0.159708202959675
down	JUP; KCNJ5; CAV1; DSG2; PKP2;	GO:0086091~regulation of heart rate by cardiac conduction	5	38	13.1578947368421	0.00212522442990071	0.0181072933489298	1	1	0.775706916913758	0.999148947208221	0.159708202959675
up	CD3G; CD8B; IRF4; TREML2;	GO:0042110~T cell activation	4	44	9.09090909090909	0.00225740075556402	0.0278266312781915	1	1	0.753971852358383	0.982323498149493	0.225392549141333
up	NMU; KCNQ1; RYR2;	GO:0010460~positive regulation of heart rate	3	20	15	0.00225743358124864	0.0278266312781915	1	1	0.753982816137044	0.982323498149493	0.225392549141333
up	NEFH; NCKAP1L; PARVG;	GO:0030031~cell projection assembly	3	20	15	0.00225743358124864	0.0278266312781915	1	1	0.753982816137044	0.982323498149493	0.225392549141333
down	NKX2-8; FGFR2; PARD3; BAIAP2; NTNG1; SLITRK6; ISL1;	GO:0007409~axonogenesis	7	78	8.97435897435897	0.00226435130810809	0.0192495189503596	1	1	0.789284137363591	0.999148947208221	0.169782751080346
down	BMP4; FGFR2; VANGL2;	GO:0003149~membranous septum morphogenesis	3	10	30	0.0023390661338536	0.0194922177821133	1	1	0.794996470908039	0.999148947208221	0.171923379916078
down	CPS1; WNT5A; SMO;	GO:0007494~midgut development	3	10	30	0.0023390661338536	0.0194922177821133	1	1	0.794996470908039	0.999148947208221	0.171923379916078
down	BMP4; FOXA1; SMO;	GO:0021904~dorsal/ventral neural tube patterning	3	10	30	0.0023390661338536	0.0194922177821133	1	1	0.794996470908039	0.999148947208221	0.171923379916078
down	GLI3; SOX9; ANXA1;	GO:0030850~prostate gland development	3	10	30	0.0023390661338536	0.0194922177821133	1	1	0.794996470908039	0.999148947208221	0.171923379916078
down	SERPINE2; AXL; TYRO3;	GO:0032940~secretion by cell	3	10	30	0.0023390661338536	0.0194922177821133	1	1	0.794996470908039	0.999148947208221	0.171923379916078
down	MMP16; STC1; HMGA2;	GO:0035988~chondrocyte proliferation	3	10	30	0.0023390661338536	0.0194922177821133	1	1	0.794996470908039	0.999148947208221	0.171923379916078
down	PDLIM4; PDLIM3; PDLIM1;	GO:0061061~muscle structure development	3	10	30	0.0023390661338536	0.0194922177821133	1	1	0.794996470908039	0.999148947208221	0.171923379916078
down	SLC1A3; SLC1A1; CXADR;	GO:0070633~transepithelial transport	3	10	30	0.0023390661338536	0.0194922177821133	1	1	0.794996470908039	0.999148947208221	0.171923379916078
down	BMP4; WNT7B; DLG5;	GO:0072205~metanephric collecting duct development	3	10	30	0.0023390661338536	0.0194922177821133	1	1	0.794996470908039	0.999148947208221	0.171923379916078
down	BMP7; PRRX1; FRAS1; HOXC10; LRP6;	GO:0030326~embryonic limb morphogenesis	5	39	12.8205128205128	0.00235622034881877	0.0195494264749156	1	1	0.796174243457533	0.999148947208221	0.172427966512488
down	TFAP2A; BMP4; BMP7; PTN; OSR1;	GO:0030501~positive regulation of bone mineralization	5	39	12.8205128205128	0.00235622034881877	0.0195494264749156	1	1	0.796174243457533	0.999148947208221	0.172427966512488
down	BAIAP2L2; A4GALT; BAIAP2L1; BAIAP2;	GO:0007009~plasma membrane organization	4	23	17.3913043478261	0.00241804982576166	0.0199090866454068	1	1	0.800374492327109	0.999148947208221	0.175600206471185
down	RHOD; EPHA3; CAMSAP3; LIMCH1;	GO:0051893~regulation of focal adhesion assembly	4	23	17.3913043478261	0.00241804982576166	0.0199090866454068	1	1	0.800374492327109	0.999148947208221	0.175600206471185
down	APOE; DLG5; SHANK3; SHANK2;	GO:0060999~positive regulation of dendritic spine development	4	23	17.3913043478261	0.00241804982576166	0.0199090866454068	1	1	0.800374492327109	0.999148947208221	0.175600206471185
down	FLRT2; RBFOX2; FGF1; FGF5; FGFR2; SPRED2; FLRT3;	GO:0008543~fibroblast growth factor receptor signaling pathway	7	79	8.86075949367089	0.00242052579741525	0.0199090866454068	1	1	0.800437511393341	0.999148947208221	0.175600206471185
down	PDLIM1; NQO1; DHCR24; SCARA3; CYGB; PXDN; RBPMS; DUOX1;	GO:0006979~response to oxidative stress	8	102	7.84313725490196	0.00248432047239588	0.0201869964939078	1	1	0.804919833056267	0.999148947208221	0.17805140012192
up	NCR3; IL18RAP; RAET1E;	GO:0045954~positive regulation of natural killer cell mediated cytotoxicity	3	21	14.2857142857143	0.00255802708235553	0.0302605240992851	1	1	0.780130787730335	0.982323498149493	0.245106804230235
down	GPR37; ADCY6; EDNRA; P2RY1; GNAI1; GPR176;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	6	59	10.1694915254237	0.00259601184764613	0.0201869964939078	1	1	0.812518842103563	0.999148947208221	0.17805140012192
down	GJA1; WNT5A; DUOXA1; DUOXA2; AJUBA; FRMD6;	GO:0034613~cellular protein localization	6	59	10.1694915254237	0.00259601184764613	0.0201869964939078	1	1	0.812518842103563	0.999148947208221	0.17805140012192
down	ADCY6; EDNRA; ADORA2B; CAP2; LGR4;	GO:0007190~activation of adenylate cyclase activity	5	40	12.5	0.00260492931411727	0.0201869964939078	1	1	0.812737946004587	0.999148947208221	0.17805140012192
down	MMP2; FBLN1; STC1; EMP2; DDR1;	GO:0007566~embryo implantation	5	40	12.5	0.00260492931411727	0.0201869964939078	1	1	0.812737946004587	0.999148947208221	0.17805140012192
down	BAG3; GLI3; CDH1; JUP; SMO;	GO:0042307~positive regulation of protein import into nucleus	5	40	12.5	0.00260492931411727	0.0201869964939078	1	1	0.812737946004587	0.999148947208221	0.17805140012192
down	KRT8; KRT19; FHOD3; SIX4; MYOM3;	GO:0045214~sarcomere organization	5	40	12.5	0.00260492931411727	0.0201869964939078	1	1	0.812737946004587	0.999148947208221	0.17805140012192
down	TNFRSF21; NGFR; GRIK2; TP63; BOK;	GO:0051402~neuron apoptotic process	5	40	12.5	0.00260492931411727	0.0201869964939078	1	1	0.812737946004587	0.999148947208221	0.17805140012192
up	HP; HBG1; HBG2; HBA1; HBM;	GO:0098869~cellular oxidant detoxification	5	77	6.49350649350649	0.00260845726092795	0.0302605240992851	1	1	0.784091261322197	0.982323498149493	0.245106804230235
up	GATA1; TAL1; PTPN2; SPI1;	GO:0030218~erythrocyte differentiation	4	46	8.69565217391304	0.00262399196687801	0.0302605240992851	1	1	0.785104299127522	0.982323498149493	0.245106804230235
up	CCR2; IRF8; IL18; IL23A;	GO:0032729~positive regulation of interferon-gamma production	4	46	8.69565217391304	0.00262399196687801	0.0302605240992851	1	1	0.785104299127522	0.982323498149493	0.245106804230235
up	TNNT2; KCNQ1; MYBPC3; RYR2;	GO:0060048~cardiac muscle contraction	4	46	8.69565217391304	0.00262399196687801	0.0302605240992851	1	1	0.785104299127522	0.982323498149493	0.245106804230235
down	CAV2; DNER; SMO; SIX1;	GO:0048741~skeletal muscle fiber development	4	24	16.6666666666667	0.00277401940530742	0.0211672163457192	1	1	0.824031124628159	0.999148947208221	0.186697040749786
down	HRAS; ANXA1; KANK1; DUOX1;	GO:0090303~positive regulation of wound healing	4	24	16.6666666666667	0.00277401940530742	0.0211672163457192	1	1	0.824031124628159	0.999148947208221	0.186697040749786
up	EREG; OSM; TAL1; MACC1;	GO:0051781~positive regulation of cell division	4	47	8.51063829787234	0.00282173557962595	0.031620539919566	1	1	0.801509463586904	0.982323498149493	0.256122777724873
down	CRYAB; WNT5A; SIX5; PROX1; SLITRK6;	GO:0002088~lens development in camera-type eye	5	41	12.1951219512195	0.0028721157420416	0.0217470859098035	1	1	0.830653529089698	0.999148947208221	0.191811550370098
up	NCR3; NCR1; IL18;	GO:0030101~natural killer cell activation	3	22	13.6363636363636	0.00288219184158578	0.031911213862827	1	1	0.807013715644018	0.982323498149493	0.258477203612275
up	LILRA5; ORM1; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	3	22	13.6363636363636	0.00288219184158578	0.031911213862827	1	1	0.807013715644018	0.982323498149493	0.258477203612275
down	BMP4; BMP7; OSR1;	GO:0001823~mesonephros development	3	11	27.2727272727273	0.00293013368047879	0.0217470859098035	1	1	0.834078262530473	0.999148947208221	0.191811550370098
down	ITGA2; KITLG; BDKRB1;	GO:0002687~positive regulation of leukocyte migration	3	11	27.2727272727273	0.00293013368047879	0.0217470859098035	1	1	0.834078262530473	0.999148947208221	0.191811550370098
down	BMP4; WNT5A; ISL1;	GO:0003139~secondary heart field specification	3	11	27.2727272727273	0.00293013368047879	0.0217470859098035	1	1	0.834078262530473	0.999148947208221	0.191811550370098
down	SOX9; HMGA2; SFRP1;	GO:0010564~regulation of cell cycle process	3	11	27.2727272727273	0.00293013368047879	0.0217470859098035	1	1	0.834078262530473	0.999148947208221	0.191811550370098
down	PLAU; PLAT; DHCR24;	GO:0031639~plasminogen activation	3	11	27.2727272727273	0.00293013368047879	0.0217470859098035	1	1	0.834078262530473	0.999148947208221	0.191811550370098
down	FUT1; FUT6; FUT10;	GO:0036065~fucosylation	3	11	27.2727272727273	0.00293013368047879	0.0217470859098035	1	1	0.834078262530473	0.999148947208221	0.191811550370098
down	NPR1; BDKRB2; HRH1;	GO:0043114~regulation of vascular permeability	3	11	27.2727272727273	0.00293013368047879	0.0217470859098035	1	1	0.834078262530473	0.999148947208221	0.191811550370098
down	ITGB4; ITGA2; TP63;	GO:0043589~skin morphogenesis	3	11	27.2727272727273	0.00293013368047879	0.0217470859098035	1	1	0.834078262530473	0.999148947208221	0.191811550370098
down	KLK8; CDH13; FERMT1;	GO:0043616~keratinocyte proliferation	3	11	27.2727272727273	0.00293013368047879	0.0217470859098035	1	1	0.834078262530473	0.999148947208221	0.191811550370098
down	PTN; JAG1; KDR;	GO:0045446~endothelial cell differentiation	3	11	27.2727272727273	0.00293013368047879	0.0217470859098035	1	1	0.834078262530473	0.999148947208221	0.191811550370098
down	TBX1; LHX1; FOXC2;	GO:0048703~embryonic viscerocranium morphogenesis	3	11	27.2727272727273	0.00293013368047879	0.0217470859098035	1	1	0.834078262530473	0.999148947208221	0.191811550370098
down	PLXNA2; FGFR2; SOX9;	GO:0060174~limb bud formation	3	11	27.2727272727273	0.00293013368047879	0.0217470859098035	1	1	0.834078262530473	0.999148947208221	0.191811550370098
down	ITGB5; BVES; CAMSAP3;	GO:0090136~epithelial cell-cell adhesion	3	11	27.2727272727273	0.00293013368047879	0.0217470859098035	1	1	0.834078262530473	0.999148947208221	0.191811550370098
down	LDLR; APOD; PC; NR2F2; PLTP; SREBF2; ANGPTL4; EPHX3; LIPG;	GO:0006629~lipid metabolic process	9	130	6.92307692307692	0.00302616909186892	0.0223744918386233	1	1	0.839130896171795	0.999148947208221	0.197345335651374
down	ADCY6; APOE; PTPRG; EFNB2; CRMP1; KANK1;	GO:0010977~negative regulation of neuron projection development	6	61	9.83606557377049	0.0030264444223822	0.0223744918386233	1	1	0.839130896171795	0.999148947208221	0.197345335651374
up	FCGR2B; SSTR3; AIF1; FOXC1;	GO:0021549~cerebellum development	4	48	8.33333333333333	0.00302943438961101	0.0333418106332783	1	1	0.818055957615798	0.982323498149493	0.270064874777419
down	GJA1; ISL1; DOC2B; AACS; TM7SF3;	GO:0032024~positive regulation of insulin secretion	5	42	11.9047619047619	0.00315854480306532	0.0229907220356741	1	1	0.846490007221506	0.999148947208221	0.202780549820823
down	BMP7; DLX2; JAG1; DLL1; JAG2;	GO:0045746~negative regulation of Notch signaling pathway	5	42	11.9047619047619	0.00315854480306532	0.0229907220356741	1	1	0.846490007221506	0.999148947208221	0.202780549820823
down	GPC4; SDC1; GPC1; GPC6;	GO:0006027~glycosaminoglycan catabolic process	4	25	16	0.00316424937490989	0.0229907220356741	1	1	0.846925032573566	0.999148947208221	0.202780549820823
down	TBX3; PRELP; TBX2; NOX4;	GO:0007569~cell aging	4	25	16	0.00316424937490989	0.0229907220356741	1	1	0.846925032573566	0.999148947208221	0.202780549820823
down	CYP2E1; FMO1; AOX1; FMO2;	GO:0017144~drug metabolic process	4	25	16	0.00316424937490989	0.0229907220356741	1	1	0.846925032573566	0.999148947208221	0.202780549820823
down	SERPINB7; BMP4; ITGA2; LARP6;	GO:0032967~positive regulation of collagen biosynthetic process	4	25	16	0.00316424937490989	0.0229907220356741	1	1	0.846925032573566	0.999148947208221	0.202780549820823
down	GJA1; PTN; GJB2; STC1;	GO:0046697~decidualization	4	25	16	0.00316424937490989	0.0229907220356741	1	1	0.846925032573566	0.999148947208221	0.202780549820823
down	WNT5A; SEMA5A; SEMA3F; SEMA6D;	GO:0048843~negative regulation of axon extension involved in axon guidance	4	25	16	0.00316424937490989	0.0229907220356741	1	1	0.846925032573566	0.999148947208221	0.202780549820823
up	IL2RA; IL18; IL23A;	GO:0042104~positive regulation of activated T cell proliferation	3	23	13.0434782608696	0.00323050954037862	0.0353194636624723	1	1	0.831228411101806	0.982323498149493	0.286083639431711
up	CXCR3; IL18; LMO7; SPINK5;	GO:0030155~regulation of cell adhesion	4	49	8.16326530612245	0.0032473276487941	0.0353194636624723	1	1	0.832026045047884	0.982323498149493	0.286083639431711
down	DLL1; IGFBP2; HMGA2; DAB2IP; KCTD11; NDN;	GO:0040008~regulation of growth	6	62	9.67741935483871	0.00326061587698523	0.0236006482524645	1	1	0.851962981610074	0.999148947208221	0.208160162231385
down	KRT19; GLI3; IGFBP2; CCND1; CAV1; CITED4;	GO:0043627~response to estrogen	6	62	9.67741935483871	0.00326061587698523	0.0236006482524645	1	1	0.851962981610074	0.999148947208221	0.208160162231385
down	HOXA5; PPP1R13L; SMO; WWTR1; SLITRK6; ETNK2; DHCR7;	GO:0035264~multicellular organism growth	7	84	8.33333333333333	0.00332933915947753	0.0240522600874802	1	1	0.855640163985725	0.999148947208221	0.21214342539589
up	EREG; S100A8; SERPINB2; NLRP6; GRHL3;	GO:0042060~wound healing	5	82	6.09756097560976	0.00337113293055213	0.0360585378118245	1	1	0.838697165324179	0.982323498149493	0.292070056000126
down	MYO1C; RHOD; LTBP2; FUT10; AP1M2;	GO:0006605~protein targeting	5	43	11.6279069767442	0.00346498128952466	0.0249846848201019	1	1	0.862968962582136	0.999148947208221	0.220367508121703
up	CD8B; TRAT1; SLA; FLT4; LTK; FLT3;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	6	120	5	0.00347779548321014	0.0360585378118245	1	1	0.84406533242151	0.982323498149493	0.292070056000126
down	C3; MSMO1; AACS; ACOT11; CYP4F11; ACOT7;	GO:0006631~fatty acid metabolic process	6	63	9.52380952380952	0.00350801621442687	0.0252470863917085	1	1	0.865935418391012	0.999148947208221	0.222681917163823
down	PLPP3; TMEM237; VANGL2; DACT2;	GO:0030111~regulation of Wnt signaling pathway	4	26	15.3846153846154	0.00359027412447865	0.025275461491587	1	1	0.870037963658606	0.999148947208221	0.222932188483952
down	DCN; CSPG4; CHST3; CHPF;	GO:0030206~chondroitin sulfate biosynthetic process	4	26	15.3846153846154	0.00359027412447865	0.025275461491587	1	1	0.870037963658606	0.999148947208221	0.222932188483952
down	RASAL1; DAB2IP; SPRY2; SPRY4;	GO:0046580~negative regulation of Ras protein signal transduction	4	26	15.3846153846154	0.00359027412447865	0.025275461491587	1	1	0.870037963658606	0.999148947208221	0.222932188483952
down	CACNB3; SHANK3; BAIAP2; SHANK2;	GO:2000463~positive regulation of excitatory postsynaptic potential	4	26	15.3846153846154	0.00359027412447865	0.025275461491587	1	1	0.870037963658606	0.999148947208221	0.222932188483952
down	EDN2; PTN; MDK;	GO:0002690~positive regulation of leukocyte chemotaxis	3	12	25	0.00360507898116846	0.025275461491587	1	1	0.871091023406438	0.999148947208221	0.222932188483952
down	ALDH7A1; CRYM; AADAT;	GO:0006554~lysine catabolic process	3	12	25	0.00360507898116846	0.025275461491587	1	1	0.871091023406438	0.999148947208221	0.222932188483952
down	PTN; SMO; LRP6;	GO:0021794~thalamus development	3	12	25	0.00360507898116846	0.025275461491587	1	1	0.871091023406438	0.999148947208221	0.222932188483952
down	MSX1; PLA2R1; SPRED2;	GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator	3	12	25	0.00360507898116846	0.025275461491587	1	1	0.871091023406438	0.999148947208221	0.222932188483952
down	BMP4; PTN; WNT5A;	GO:0045778~positive regulation of ossification	3	12	25	0.00360507898116846	0.025275461491587	1	1	0.871091023406438	0.999148947208221	0.222932188483952
down	BCAR1; MST1R; MUC20;	GO:0048012~hepatocyte growth factor receptor signaling pathway	3	12	25	0.00360507898116846	0.025275461491587	1	1	0.871091023406438	0.999148947208221	0.222932188483952
down	FLRT3; MSX1; MSX2;	GO:0048598~embryonic morphogenesis	3	12	25	0.00360507898116846	0.025275461491587	1	1	0.871091023406438	0.999148947208221	0.222932188483952
down	SPINT1; FOSL1; NR2F2;	GO:0060674~placenta blood vessel development	3	12	25	0.00360507898116846	0.025275461491587	1	1	0.871091023406438	0.999148947208221	0.222932188483952
down	NFIB; GDNF; SMO;	GO:0071679~commissural neuron axon guidance	3	12	25	0.00360507898116846	0.025275461491587	1	1	0.871091023406438	0.999148947208221	0.222932188483952
down	SEMA3F; PLXNA2; PLXNB1;	GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance	3	12	25	0.00360507898116846	0.025275461491587	1	1	0.871091023406438	0.999148947208221	0.222932188483952
down	FOXE1; TBX1; HES1; SIX1; SIX4;	GO:0048538~thymus development	5	44	11.3636363636364	0.00379218850730489	0.026538335778561	1	1	0.881101007076839	0.999148947208221	0.23407087050837
down	NGFR; F3; XDH; DLC1; BCL2L10; BOK; ROBO1;	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	7	87	8.04597701149425	0.00398720384757434	0.0271618231775572	1	1	0.892177142854146	0.999148947208221	0.239570093950707
up	RNASE2; RNASE3; RNASE6;	GO:0006401~RNA catabolic process	3	25	12	0.00400178260429185	0.0404333116685007	1	1	0.869718951979518	0.982323498149493	0.327505226776472
up	TNNT2; FOXC1; MYBPC3;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	3	25	12	0.00400178260429185	0.0404333116685007	1	1	0.869718951979518	0.982323498149493	0.327505226776472
down	YAP1; AMOTL1; TEAD3; WWTR1;	GO:0035329~hippo signaling	4	27	14.8148148148148	0.00405359485053847	0.0271618231775572	1	1	0.895395495213065	0.999148947208221	0.239570093950707
down	SPRY2; ANXA1; KDR; DAB2IP;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	4	27	14.8148148148148	0.00405359485053847	0.0271618231775572	1	1	0.895395495213065	0.999148947208221	0.239570093950707
down	BDKRB1; VEGFC; APLN; NOS1;	GO:0045776~negative regulation of blood pressure	4	27	14.8148148148148	0.00405359485053847	0.0271618231775572	1	1	0.895395495213065	0.999148947208221	0.239570093950707
down	ITGB4; EPHA2; DST; CTTN;	GO:0048870~cell motility	4	27	14.8148148148148	0.00405359485053847	0.0271618231775572	1	1	0.895395495213065	0.999148947208221	0.239570093950707
down	PTPN3; PPP2R3A; PTPN14; PTPN21; PTPRU; CTTNBP2NL; PPP1R3C; PTPRF; PTPRG;	GO:0006470~protein dephosphorylation	9	137	6.56934306569343	0.00418764364456592	0.0271618231775572	1	1	0.89695996026003	0.999148947208221	0.239570093950707
up	CNR2; CCR2; NMU; PROK2;	GO:0019233~sensory perception of pain	4	53	7.54716981132075	0.0042255338252053	0.0417808130631262	1	1	0.878911035642702	0.982323498149493	0.338419834846338
up	TAL1; FLT3; CCR2; ANGPT1;	GO:0030097~hemopoiesis	4	53	7.54716981132075	0.0042255338252053	0.0417808130631262	1	1	0.878911035642702	0.982323498149493	0.338419834846338
up	EREG; SCEL; CSTA; CERS3;	GO:0030216~keratinocyte differentiation	4	53	7.54716981132075	0.0042255338252053	0.0417808130631262	1	1	0.878911035642702	0.982323498149493	0.338419834846338
up	SCIMP; LILRB2; TLR8; TLR7;	GO:0032755~positive regulation of interleukin-6 production	4	53	7.54716981132075	0.0042255338252053	0.0417808130631262	1	1	0.878911035642702	0.982323498149493	0.338419834846338
down	FZD6; GPC4; WNT5A; ROR1; PRICKLE2; VANGL1; GPC6;	GO:0060071~Wnt signaling pathway, planar cell polarity pathway	7	88	7.95454545454545	0.00422699528886994	0.0271618231775572	1	1	0.897502308142978	0.999148947208221	0.239570093950707
up	OSM; FLT3; IL18; ANGPT1; PIK3R5;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	5	87	5.74712643678161	0.00428220093186271	0.0418930662593342	1	1	0.881254961069552	0.982323498149493	0.339329072971127
up	GPR15; SLAMF1; CLEC4G; NECTIN4; LAMP3;	GO:0046718~viral entry into host cell	5	87	5.74712643678161	0.00428220093186271	0.0418930662593342	1	1	0.881254961069552	0.982323498149493	0.339329072971127
down	NQO1; NOS1; SPR;	GO:0006809~nitric oxide biosynthetic process	3	13	23.0769230769231	0.00436733525302302	0.0271618231775572	1	1	0.899489043652015	0.999148947208221	0.239570093950707
down	IGFBP5; SEMA6D; NDRG4;	GO:0014912~negative regulation of smooth muscle cell migration	3	13	23.0769230769231	0.00436733525302302	0.0271618231775572	1	1	0.899489043652015	0.999148947208221	0.239570093950707
down	SLC16A2; SLC16A9; SLC16A12;	GO:0015718~monocarboxylic acid transport	3	13	23.0769230769231	0.00436733525302302	0.0271618231775572	1	1	0.899489043652015	0.999148947208221	0.239570093950707
down	SLC6A17; SLC6A15; SLC7A8;	GO:0015804~neutral amino acid transport	3	13	23.0769230769231	0.00436733525302302	0.0271618231775572	1	1	0.899489043652015	0.999148947208221	0.239570093950707
down	APOE; SERPINE2; TFPI;	GO:0030195~negative regulation of blood coagulation	3	13	23.0769230769231	0.00436733525302302	0.0271618231775572	1	1	0.899489043652015	0.999148947208221	0.239570093950707
down	PLAU; EFNA1; EPHA2;	GO:0033628~regulation of cell adhesion mediated by integrin	3	13	23.0769230769231	0.00436733525302302	0.0271618231775572	1	1	0.899489043652015	0.999148947208221	0.239570093950707
down	NRP2; KDR; VEGFC;	GO:0038084~vascular endothelial growth factor signaling pathway	3	13	23.0769230769231	0.00436733525302302	0.0271618231775572	1	1	0.899489043652015	0.999148947208221	0.239570093950707
down	CDH3; IGFBP4; IGFBP5;	GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway	3	13	23.0769230769231	0.00436733525302302	0.0271618231775572	1	1	0.899489043652015	0.999148947208221	0.239570093950707
down	PLPP3; PLPP2; PLPPR5;	GO:0046839~phospholipid dephosphorylation	3	13	23.0769230769231	0.00436733525302302	0.0271618231775572	1	1	0.899489043652015	0.999148947208221	0.239570093950707
down	DLX2; HES1; TMEM98;	GO:0048715~negative regulation of oligodendrocyte differentiation	3	13	23.0769230769231	0.00436733525302302	0.0271618231775572	1	1	0.899489043652015	0.999148947208221	0.239570093950707
down	EDNRA; LHX1; FLRT3;	GO:0060322~head development	3	13	23.0769230769231	0.00436733525302302	0.0271618231775572	1	1	0.899489043652015	0.999148947208221	0.239570093950707
down	HOXA5; SMO; ELF5;	GO:0060644~mammary gland epithelial cell differentiation	3	13	23.0769230769231	0.00436733525302302	0.0271618231775572	1	1	0.899489043652015	0.999148947208221	0.239570093950707
down	WNT5A; SFRP1; VANGL2;	GO:0090179~planar cell polarity pathway involved in neural tube closure	3	13	23.0769230769231	0.00436733525302302	0.0271618231775572	1	1	0.899489043652015	0.999148947208221	0.239570093950707
down	TERT; CHEK1; PLA2R1;	GO:0090399~replicative senescence	3	13	23.0769230769231	0.00436733525302302	0.0271618231775572	1	1	0.899489043652015	0.999148947208221	0.239570093950707
down	SNX33; EHD2; PACSIN3;	GO:0097320~plasma membrane tubulation	3	13	23.0769230769231	0.00436733525302302	0.0271618231775572	1	1	0.899489043652015	0.999148947208221	0.239570093950707
up	XCL1; NCKAP1L; IL23A;	GO:0090023~positive regulation of neutrophil chemotaxis	3	26	11.5384615384615	0.0044257557067664	0.042058431356306	1	1	0.886569168155541	0.982323498149493	0.340668511452662
down	LAMA5; TBX1; CRYAB; MSX1; CTF1; BVES; JPH1;	GO:0007517~muscle organ development	7	89	7.86516853932584	0.00447753023795572	0.0277434093751671	1	1	0.900690395433746	0.999148947208221	0.24469974445653
down	DLL1; PLXNA2; WNT5A; FOXC2; TBX18;	GO:0001756~somitogenesis	5	46	10.8695652173913	0.00451195447206665	0.0277434093751671	1	1	0.901310344347848	0.999148947208221	0.24469974445653
down	CCND1; XDH; CAV1; DDR1; APLN;	GO:0007595~lactation	5	46	10.8695652173913	0.00451195447206665	0.0277434093751671	1	1	0.901310344347848	0.999148947208221	0.24469974445653
down	MYO1D; NR2F2; SOX2; POU3F1; DLC1;	GO:0030900~forebrain development	5	46	10.8695652173913	0.00451195447206665	0.0277434093751671	1	1	0.901310344347848	0.999148947208221	0.24469974445653
down	GJA1; IGFBP2; GJB2; TRIML2; AQP3;	GO:0032526~response to retinoic acid	5	46	10.8695652173913	0.00451195447206665	0.0277434093751671	1	1	0.901310344347848	0.999148947208221	0.24469974445653
down	SPRY2; HRAS; DAB2IP; RTKN; FZD10;	GO:0034260~negative regulation of GTPase activity	5	46	10.8695652173913	0.00451195447206665	0.0277434093751671	1	1	0.901310344347848	0.999148947208221	0.24469974445653
down	TGFB1I1; MSX2; WNT5A; JAG1; WWTR1;	GO:0045599~negative regulation of fat cell differentiation	5	46	10.8695652173913	0.00451195447206665	0.0277434093751671	1	1	0.901310344347848	0.999148947208221	0.24469974445653
down	SHANK2; SHANK3; ADRA1D; ADRA1B;	GO:0007610~behavior	4	28	14.2857142857143	0.00455567684433955	0.0279669983982073	1	1	0.901943697562795	0.999148947208221	0.246671822799943
up	JCHAIN; VIL1; CD3G; NCKAP1L; OCLN; NFE4;	GO:0065003~protein-containing complex assembly	6	128	4.6875	0.00469557558417311	0.0436287399755582	1	1	0.897015780506156	0.982323498149493	0.353387832706228
down	B4GALT2; FUT1; FUT6; FUT10; B3GALNT1; B3GNT9; B3GALT5;	GO:0006486~protein glycosylation	7	90	7.77777777777778	0.00473910625957874	0.0290461351393536	1	1	0.904272515985171	0.999148947208221	0.256189920637929
up	F13A1; GP9; GATA1; GP5; P2RX1; HBG1; HBG2;	GO:0007596~blood coagulation	7	171	4.09356725146199	0.00475015185899552	0.0439151539364136	1	1	0.899507491007562	0.982323498149493	0.355707753220554
up	F13A1; CSTA; EPB42;	GO:0018149~peptide cross-linking	3	27	11.1111111111111	0.0048759186903562	0.0446315527646961	1	1	0.903974316419795	0.982323498149493	0.361510502266753
up	GJB6; AIF1; EEF1A2;	GO:0051602~response to electrical stimulus	3	27	11.1111111111111	0.0048759186903562	0.0446315527646961	1	1	0.903974316419795	0.982323498149493	0.361510502266753
down	MEIS2; B4GALT2; HRH1; LRRN4; NDRG4;	GO:0008542~visual learning	5	47	10.6382978723404	0.00490602280886676	0.0299724866136555	1	1	0.906419516357959	0.999148947208221	0.264360436596271
down	ZNF423; ACOT11; FOXC2; LGR4; HOXC10;	GO:0120163~negative regulation of cold-induced thermogenesis	5	47	10.6382978723404	0.00490602280886676	0.0299724866136555	1	1	0.906419516357959	0.999148947208221	0.264360436596271
down	TGFB1I1; CAV2; CAV1; VASN; CD109; ASPN;	GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway	6	68	8.82352941176471	0.00495914806867592	0.0302484151861453	1	1	0.907168861586109	0.999148947208221	0.266794155187359
down	COL4A1; EDNRA; KDR; FOXC2;	GO:0001569~branching involved in blood vessel morphogenesis	4	29	13.7931034482759	0.00509794703422484	0.0309460043611092	1	1	0.908721721576973	0.999148947208221	0.272946963969473
down	PLXNA2; EPHA2; PROX1; INTU;	GO:0021915~neural tube development	4	29	13.7931034482759	0.00509794703422484	0.0309460043611092	1	1	0.908721721576973	0.999148947208221	0.272946963969473
down	ERBB2; FGFR2; EPHA2; ARHGEF5;	GO:0070372~regulation of ERK1 and ERK2 cascade	4	29	13.7931034482759	0.00509794703422484	0.0309460043611092	1	1	0.908721721576973	0.999148947208221	0.272946963969473
down	CYP7B1; ISL1; TP63;	GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway	3	14	21.4285714285714	0.00521999806691364	0.0312377837075147	1	1	0.910351266011831	0.999148947208221	0.275520488028381
down	EDN2; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	3	14	21.4285714285714	0.00521999806691364	0.0312377837075147	1	1	0.910351266011831	0.999148947208221	0.275520488028381
down	IGFBP5; BVES; POPDC3;	GO:0051146~striated muscle cell differentiation	3	14	21.4285714285714	0.00521999806691364	0.0312377837075147	1	1	0.910351266011831	0.999148947208221	0.275520488028381
down	NOS1; STC1; PACSIN3;	GO:0051926~negative regulation of calcium ion transport	3	14	21.4285714285714	0.00521999806691364	0.0312377837075147	1	1	0.910351266011831	0.999148947208221	0.275520488028381
down	SOX15; NR2F2; MDFI;	GO:0060707~trophoblast giant cell differentiation	3	14	21.4285714285714	0.00521999806691364	0.0312377837075147	1	1	0.910351266011831	0.999148947208221	0.275520488028381
down	DLL1; PITX2; SMO;	GO:0070986~left/right axis specification	3	14	21.4285714285714	0.00521999806691364	0.0312377837075147	1	1	0.910351266011831	0.999148947208221	0.275520488028381
down	NFIB; BMP4; SOX9;	GO:1902894~negative regulation of pri-miRNA transcription by RNA polymerase II	3	14	21.4285714285714	0.00521999806691364	0.0312377837075147	1	1	0.910351266011831	0.999148947208221	0.275520488028381
down	PTN; HMGA2; SMO;	GO:2000036~regulation of stem cell population maintenance	3	14	21.4285714285714	0.00521999806691364	0.0312377837075147	1	1	0.910351266011831	0.999148947208221	0.275520488028381
down	MYO1C; SNAI2; GJA1;	GO:2000810~regulation of bicellular tight junction assembly	3	14	21.4285714285714	0.00521999806691364	0.0312377837075147	1	1	0.910351266011831	0.999148947208221	0.275520488028381
down	RHOD; ERBB2; ITGA2; MDK; FRMD5;	GO:0045785~positive regulation of cell adhesion	5	48	10.4166666666667	0.00532387903645093	0.0318093401548955	1	1	0.911627230050446	0.999148947208221	0.280561675098264
up	MS4A1; CXCR5; FCRL1;	GO:0042113~B cell activation	3	28	10.7142857142857	0.00535271201186549	0.0484996925236927	1	1	0.913630098479396	0.982323498149493	0.39284199446209
up	NCKAP1L; GPR174; SIT1;	GO:0043029~T cell homeostasis	3	28	10.7142857142857	0.00535271201186549	0.0484996925236927	1	1	0.913630098479396	0.982323498149493	0.39284199446209
up	EREG; ELANE; AIF1; IL18;	GO:0048661~positive regulation of smooth muscle cell proliferation	4	57	7.01754385964912	0.00538524372725657	0.0484996925236927	1	1	0.91434248062246	0.982323498149493	0.39284199446209
down	TERT; CSF3; BMP4; WNT5A; CAV1; PLK2;	GO:0032092~positive regulation of protein binding	6	70	8.57142857142857	0.0056479435843001	0.0335261004966693	1	1	0.915761353535558	0.999148947208221	0.295703679141256
down	BMP7; WNT5A; PLK1; TNKS1BP1;	GO:0010800~positive regulation of peptidyl-threonine phosphorylation	4	30	13.3333333333333	0.0056817917683829	0.0335261004966693	1	1	0.916251529250795	0.999148947208221	0.295703679141256
down	LGI3; PCLO; RAB13; RAB3B;	GO:0017157~regulation of exocytosis	4	30	13.3333333333333	0.0056817917683829	0.0335261004966693	1	1	0.916251529250795	0.999148947208221	0.295703679141256
down	HMGA2; ZNF462; MDFI; SMO;	GO:0043392~negative regulation of DNA binding	4	30	13.3333333333333	0.0056817917683829	0.0335261004966693	1	1	0.916251529250795	0.999148947208221	0.295703679141256
down	APOD; NPR1; IGFBP5; NDRG4;	GO:0048662~negative regulation of smooth muscle cell proliferation	4	30	13.3333333333333	0.0056817917683829	0.0335261004966693	1	1	0.916251529250795	0.999148947208221	0.295703679141256
down	MATN2; KCNK2; APOD; FLRT3;	GO:0048678~response to axon injury	4	30	13.3333333333333	0.0056817917683829	0.0335261004966693	1	1	0.916251529250795	0.999148947208221	0.295703679141256
down	HRAS; CRYAB; YAP1; NOX4;	GO:0071480~cellular response to gamma radiation	4	30	13.3333333333333	0.0056817917683829	0.0335261004966693	1	1	0.916251529250795	0.999148947208221	0.295703679141256
down	TERT; KDR; SEMA5A; ANGPTL4;	GO:2000352~negative regulation of endothelial cell apoptotic process	4	30	13.3333333333333	0.0056817917683829	0.0335261004966693	1	1	0.916251529250795	0.999148947208221	0.295703679141256
down	BMP4; JAG1; ROBO1;	GO:0003184~pulmonary valve morphogenesis	3	15	20	0.00616584139126064	0.0342694993739801	1	1	0.922691794122523	0.999148947208221	0.302260534243212
down	NFIB; FGF5; DNER;	GO:0010001~glial cell differentiation	3	15	20	0.00616584139126064	0.0342694993739801	1	1	0.922691794122523	0.999148947208221	0.302260534243212
down	TBX2; FOXC2; NDRG4;	GO:0035050~embryonic heart tube development	3	15	20	0.00616584139126064	0.0342694993739801	1	1	0.922691794122523	0.999148947208221	0.302260534243212
down	KRT14; KRT16; PPP1R13L;	GO:0042633~hair cycle	3	15	20	0.00616584139126064	0.0342694993739801	1	1	0.922691794122523	0.999148947208221	0.302260534243212
down	EPHA3; SNX33; PACSIN3;	GO:0045806~negative regulation of endocytosis	3	15	20	0.00616584139126064	0.0342694993739801	1	1	0.922691794122523	0.999148947208221	0.302260534243212
down	SHISA9; UNC13B; GRIK2;	GO:0048172~regulation of short-term neuronal synaptic plasticity	3	15	20	0.00616584139126064	0.0342694993739801	1	1	0.922691794122523	0.999148947208221	0.302260534243212
down	OBSL1; FHOD3; MYOM3;	GO:0055003~cardiac myofibril assembly	3	15	20	0.00616584139126064	0.0342694993739801	1	1	0.922691794122523	0.999148947208221	0.302260534243212
down	KCNK2; GJA1; CXADR;	GO:0060044~negative regulation of cardiac muscle cell proliferation	3	15	20	0.00616584139126064	0.0342694993739801	1	1	0.922691794122523	0.999148947208221	0.302260534243212
down	WNT5A; LHX1; FOXL2;	GO:0060065~uterus development	3	15	20	0.00616584139126064	0.0342694993739801	1	1	0.922691794122523	0.999148947208221	0.302260534243212
down	COBL; HRAS; EPS8L2;	GO:1900029~positive regulation of ruffle assembly	3	15	20	0.00616584139126064	0.0342694993739801	1	1	0.922691794122523	0.999148947208221	0.302260534243212
down	YAP1; JAG1; HES1;	GO:2000737~negative regulation of stem cell differentiation	3	15	20	0.00616584139126064	0.0342694993739801	1	1	0.922691794122523	0.999148947208221	0.302260534243212
down	PTN; HRH1; CX3CL1; PLK2; BAIAP2;	GO:0048167~regulation of synaptic plasticity	5	50	10	0.00623390852845895	0.0342694993739801	1	1	0.923279783991327	0.999148947208221	0.302260534243212
down	SPRY2; GJA1; PLK1; MISP;	GO:0000132~establishment of mitotic spindle orientation	4	31	12.9032258064516	0.00630855482578419	0.0342694993739801	1	1	0.924482091633507	0.999148947208221	0.302260534243212
down	WNT9A; HRAS; TICRR; PLK2;	GO:0007093~mitotic cell cycle checkpoint	4	31	12.9032258064516	0.00630855482578419	0.0342694993739801	1	1	0.924482091633507	0.999148947208221	0.302260534243212
down	FGFR2; GDNF; WNT7B; TEAD3;	GO:0048568~embryonic organ development	4	31	12.9032258064516	0.00630855482578419	0.0342694993739801	1	1	0.924482091633507	0.999148947208221	0.302260534243212
down	PLXNB1; ARHGEF5; SYDE1; CAPN6;	GO:0051493~regulation of cytoskeleton organization	4	31	12.9032258064516	0.00630855482578419	0.0342694993739801	1	1	0.924482091633507	0.999148947208221	0.302260534243212
down	MYO1C; HRAS; ERBB2; CACNB3;	GO:0090314~positive regulation of protein targeting to membrane	4	31	12.9032258064516	0.00630855482578419	0.0342694993739801	1	1	0.924482091633507	0.999148947208221	0.302260534243212
down	HPGD; ITGB5; LTBP2; PARD3; FERMT2; CGN; TGFB1I1;	GO:0007179~transforming growth factor beta receptor signaling pathway	7	96	7.29166666666667	0.00655723410898368	0.0349964741771601	1	1	0.927650964488866	0.999148947208221	0.308672527310066
down	MYO1C; WNT5A; STXBP1; GBP6; RAB7B; CX3CL1; CCL26;	GO:0071346~cellular response to interferon-gamma	7	96	7.29166666666667	0.00655723410898368	0.0349964741771601	1	1	0.927650964488866	0.999148947208221	0.308672527310066
up	ADRB2; CCR2; FABP5; IL18; IRF4;	GO:0120162~positive regulation of cold-induced thermogenesis	5	97	5.15463917525773	0.0066082196002708	0.0569560172491226	1	1	0.938367183238454	0.982323498149493	0.461337263155477
down	FGF1; GHR; ADORA2B; WNT5A; CSPG4; CXCL17; LPAR3; MUC20;	GO:0000187~activation of MAPK activity	8	122	6.55737704918033	0.00681792919086877	0.0363367895165516	1	1	0.931075391606755	0.999148947208221	0.320494247438445
up	ASS1; S100A8; HAAO;	GO:0010043~response to zinc ion	3	31	9.67741935483871	0.00694689121983982	0.0578594678625398	1	1	0.944777205898216	0.982323498149493	0.468655110391301
up	GATA1; TAL1; NCKAP1L;	GO:0045648~positive regulation of erythrocyte differentiation	3	31	9.67741935483871	0.00694689121983982	0.0578594678625398	1	1	0.944777205898216	0.982323498149493	0.468655110391301
down	AXL; JAG1; EPAS1; FOXC2;	GO:0001974~blood vessel remodeling	4	32	12.5	0.00697953564279508	0.0370940355840857	1	1	0.933265892920181	0.999148947208221	0.327173236192515
down	PLXNB1; PLXNA2; SEMA6D; SEMA3F;	GO:0071526~semaphorin-plexin signaling pathway	4	32	12.5	0.00697953564279508	0.0370940355840857	1	1	0.933265892920181	0.999148947208221	0.327173236192515
down	CNTN1; PKP2; PRSS8;	GO:0010765~positive regulation of sodium ion transport	3	16	18.75	0.00720733303775734	0.0379333317776702	1	1	0.936361302183597	0.999148947208221	0.334575915557413
down	MDK; PROX1; SMO;	GO:0021542~dentate gyrus development	3	16	18.75	0.00720733303775734	0.0379333317776702	1	1	0.936361302183597	0.999148947208221	0.334575915557413
down	BMP7; STC1; AQP3;	GO:0033280~response to vitamin D	3	16	18.75	0.00720733303775734	0.0379333317776702	1	1	0.936361302183597	0.999148947208221	0.334575915557413
down	INHA; BMP4; BMP7;	GO:0042326~negative regulation of phosphorylation	3	16	18.75	0.00720733303775734	0.0379333317776702	1	1	0.936361302183597	0.999148947208221	0.334575915557413
down	C3; WNT5A; KLK5;	GO:0045745~positive regulation of G protein-coupled receptor signaling pathway	3	16	18.75	0.00720733303775734	0.0379333317776702	1	1	0.936361302183597	0.999148947208221	0.334575915557413
down	DOC2B; SYT8; SYT12;	GO:0048791~calcium ion-regulated exocytosis of neurotransmitter	3	16	18.75	0.00720733303775734	0.0379333317776702	1	1	0.936361302183597	0.999148947208221	0.334575915557413
down	GJA1; CD109; WFDC1;	GO:0061045~negative regulation of wound healing	3	16	18.75	0.00720733303775734	0.0379333317776702	1	1	0.936361302183597	0.999148947208221	0.334575915557413
down	IL33; PLK1; SH3RF2; PLK2; RNF180; HSPA1B;	GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process	6	74	8.10810810810811	0.0072310968871081	0.0380057651051325	1	1	0.936361302183597	0.999148947208221	0.335214785008549
down	EYA2; PTPRF; PTPRG; PTPN3; PTPN14; PTPN21; PTPRU;	GO:0035335~peptidyl-tyrosine dephosphorylation	7	99	7.07070707070707	0.00763975112002291	0.0400065026344305	1	1	0.941422714627833	0.999148947208221	0.352861497260939
down	APOE; CYP2E1; CAV1; PCSK9;	GO:0006641~triglyceride metabolic process	4	33	12.1212121212121	0.00769598774362334	0.0400065026344305	1	1	0.942319965015675	0.999148947208221	0.352861497260939
down	LDLR; APOE; NTF4; LRRN4;	GO:0007616~long-term memory	4	33	12.1212121212121	0.00769598774362334	0.0400065026344305	1	1	0.942319965015675	0.999148947208221	0.352861497260939
down	ERBB2; TYRO3; NYAP1; PIK3C2G;	GO:0014065~phosphatidylinositol 3-kinase signaling	4	33	12.1212121212121	0.00769598774362334	0.0400065026344305	1	1	0.942319965015675	0.999148947208221	0.352861497260939
down	RHOD; CDH13; AJUBA; ABLIM2;	GO:0030032~lamellipodium assembly	4	33	12.1212121212121	0.00769598774362334	0.0400065026344305	1	1	0.942319965015675	0.999148947208221	0.352861497260939
down	HOXD8; FGFR2; HOXC8; NKX3-2;	GO:0048705~skeletal system morphogenesis	4	33	12.1212121212121	0.00769598774362334	0.0400065026344305	1	1	0.942319965015675	0.999148947208221	0.352861497260939
down	TERT; MMP2; HPGD; IGFBP5;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	4	33	12.1212121212121	0.00769598774362334	0.0400065026344305	1	1	0.942319965015675	0.999148947208221	0.352861497260939
down	TNFRSF21; POSTN; DAB2IP; SFRP1; HAS2; ADAMTS7; CX3CL1; CCL26;	GO:0071356~cellular response to tumor necrosis factor	8	125	6.4	0.00778483658729334	0.0401399659747637	1	1	0.943233678713385	0.999148947208221	0.354038657747316
down	KCNU1; KCNK2; SLC1A3; KCNIP3; KCNS3; SLC9A3; KCNF1; KCNS2;	GO:0071805~potassium ion transmembrane transport	8	125	6.4	0.00778483658729334	0.0401399659747637	1	1	0.943233678713385	0.999148947208221	0.354038657747316
down	GJA1; GJB2; CX3CL1; CAV1; BVES;	GO:0002931~response to ischemia	5	53	9.43396226415094	0.00779560391825673	0.0401399659747637	1	1	0.943268074109065	0.999148947208221	0.354038657747316
down	PARD3; PARVA; PARD6G; CAP2; RHOD;	GO:0007163~establishment or maintenance of cell polarity	5	53	9.43396226415094	0.00779560391825673	0.0401399659747637	1	1	0.943268074109065	0.999148947208221	0.354038657747316
down	DLL1; CRIP2; JAG1; FUT10; MECOM;	GO:0030097~hemopoiesis	5	53	9.43396226415094	0.00779560391825673	0.0401399659747637	1	1	0.943268074109065	0.999148947208221	0.354038657747316
down	HSPA1B; CAV1; NXN; SH3RF2; RASD2;	GO:0031397~negative regulation of protein ubiquitination	5	53	9.43396226415094	0.00779560391825673	0.0401399659747637	1	1	0.943268074109065	0.999148947208221	0.354038657747316
down	TNFRSF21; NFASC; ERBB2; MAL; MALL;	GO:0042552~myelination	5	53	9.43396226415094	0.00779560391825673	0.0401399659747637	1	1	0.943268074109065	0.999148947208221	0.354038657747316
down	LHX1; LRP5; LRP6;	GO:0001702~gastrulation with mouth forming second	3	17	17.6470588235294	0.00834664952960273	0.042346152486636	1	1	0.951194748554823	0.999148947208221	0.373497451307196
down	DLL1; JAG1; PROX1;	GO:0001709~cell fate determination	3	17	17.6470588235294	0.00834664952960273	0.042346152486636	1	1	0.951194748554823	0.999148947208221	0.373497451307196
down	MSX2; ECM1; SULF1;	GO:0002063~chondrocyte development	3	17	17.6470588235294	0.00834664952960273	0.042346152486636	1	1	0.951194748554823	0.999148947208221	0.373497451307196
down	FOXE1; SLC16A2; DUOX1;	GO:0006590~thyroid hormone generation	3	17	17.6470588235294	0.00834664952960273	0.042346152486636	1	1	0.951194748554823	0.999148947208221	0.373497451307196
down	C1R; PRSS3; PRSS12;	GO:0031638~zymogen activation	3	17	17.6470588235294	0.00834664952960273	0.042346152486636	1	1	0.951194748554823	0.999148947208221	0.373497451307196
down	APOE; PLTP; LIPG;	GO:0034375~high-density lipoprotein particle remodeling	3	17	17.6470588235294	0.00834664952960273	0.042346152486636	1	1	0.951194748554823	0.999148947208221	0.373497451307196
down	LAMA1; WNT5A; CAMSAP3;	GO:0045198~establishment of epithelial cell apical/basal polarity	3	17	17.6470588235294	0.00834664952960273	0.042346152486636	1	1	0.951194748554823	0.999148947208221	0.373497451307196
down	SPRY4; SPRY2; BARX1;	GO:0048513~animal organ development	3	17	17.6470588235294	0.00834664952960273	0.042346152486636	1	1	0.951194748554823	0.999148947208221	0.373497451307196
down	FOSL1; CCND1; MAOB;	GO:0051412~response to corticosterone	3	17	17.6470588235294	0.00834664952960273	0.042346152486636	1	1	0.951194748554823	0.999148947208221	0.373497451307196
down	STXBP1; PLK2; SHANK2;	GO:0060292~long-term synaptic depression	3	17	17.6470588235294	0.00834664952960273	0.042346152486636	1	1	0.951194748554823	0.999148947208221	0.373497451307196
down	SNAI2; CAV1; NTRK2;	GO:2000811~negative regulation of anoikis	3	17	17.6470588235294	0.00834664952960273	0.042346152486636	1	1	0.951194748554823	0.999148947208221	0.373497451307196
down	ARHGEF5; DAB2IP; VANGL2; FZD10;	GO:0043507~positive regulation of JUN kinase activity	4	34	11.7647058823529	0.00845911736466809	0.0428024580369357	1	1	0.952279444320719	0.999148947208221	0.377522113526699
down	LMNA; BMP4; YAP1; CTTN;	GO:2001237~negative regulation of extrinsic apoptotic signaling pathway	4	34	11.7647058823529	0.00845911736466809	0.0428024580369357	1	1	0.952279444320719	0.999148947208221	0.377522113526699
up	XCL1; LILRB1; BATF3; TLR8; TBX21;	GO:0009615~response to virus	5	104	4.80769230769231	0.00868589619593196	0.0704395704661325	1	1	0.980272298959563	0.982323498149493	0.57055251097624
up	A2ML1; CSTA; SERPINB8; SERPINB13; SERPINB2; SERPINB12;	GO:0010951~negative regulation of endopeptidase activity	6	148	4.05405405405405	0.00907756093264234	0.0732943675303741	1	1	0.982323498149493	0.982323498149493	0.593676042572927
down	IL33; LDLR; ITGA2; MDK; WNT5A; CX3CL1;	GO:0050729~positive regulation of inflammatory response	6	78	7.69230769230769	0.00911210688951347	0.0442222301151356	1	1	0.960525464820594	0.999148947208221	0.390044650321798
down	PDPN; SLC6A15; SLC38A4; SLC7A8;	GO:0003333~amino acid transmembrane transport	4	35	11.4285714285714	0.00927008225942305	0.0448715771319716	1	1	0.962931996751947	0.999148947208221	0.395771958272118
down	TERT; NGFR; APLN; SREBF2;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	4	35	11.4285714285714	0.00927008225942305	0.0448715771319716	1	1	0.962931996751947	0.999148947208221	0.395771958272118
down	ADCY6; ADORA2B; GPR161; UCN2; LGR4; ADGRL3; ADGRL2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	7	103	6.79611650485437	0.00928133148045518	0.0448715771319716	1	1	0.962931996751947	0.999148947208221	0.395771958272118
up	EREG; PTPN2; EPGN;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	3	35	8.57142857142857	0.00946760222309351	0.0741762564004233	1	1	0.982323498149493	0.982323498149493	0.600819242139291
down	SOX9; ISL1; TBX2;	GO:0003203~endocardial cushion morphogenesis	3	18	16.6666666666667	0.0095856904108248	0.0455890157210691	1	1	0.966677194664984	0.999148947208221	0.402099840942968
down	SPRY2; SPRED2; PARD3;	GO:0010801~negative regulation of peptidyl-threonine phosphorylation	3	18	16.6666666666667	0.0095856904108248	0.0455890157210691	1	1	0.966677194664984	0.999148947208221	0.402099840942968
down	BMP4; LHX1; HES1;	GO:0021537~telencephalon development	3	18	16.6666666666667	0.0095856904108248	0.0455890157210691	1	1	0.966677194664984	0.999148947208221	0.402099840942968
down	POU3F1; NTRK2; PARD3;	GO:0022011~myelination in peripheral nervous system	3	18	16.6666666666667	0.0095856904108248	0.0455890157210691	1	1	0.966677194664984	0.999148947208221	0.402099840942968
down	SOX2; MAGI1; MYO10;	GO:0022409~positive regulation of cell-cell adhesion	3	18	16.6666666666667	0.0095856904108248	0.0455890157210691	1	1	0.966677194664984	0.999148947208221	0.402099840942968
down	FOSL1; ADORA2B; AXL;	GO:0031668~cellular response to extracellular stimulus	3	18	16.6666666666667	0.0095856904108248	0.0455890157210691	1	1	0.966677194664984	0.999148947208221	0.402099840942968
down	SNAI2; NOS1; ISL1;	GO:0035066~positive regulation of histone acetylation	3	18	16.6666666666667	0.0095856904108248	0.0455890157210691	1	1	0.966677194664984	0.999148947208221	0.402099840942968
down	SLCO2B1; SLC16A2; SLCO2A1;	GO:0043252~sodium-independent organic anion transport	3	18	16.6666666666667	0.0095856904108248	0.0455890157210691	1	1	0.966677194664984	0.999148947208221	0.402099840942968
down	DLL1; MEIS2; HMGB3;	GO:0045638~negative regulation of myeloid cell differentiation	3	18	16.6666666666667	0.0095856904108248	0.0455890157210691	1	1	0.966677194664984	0.999148947208221	0.402099840942968
down	GLI3; SHROOM2; TENM3;	GO:0048593~camera-type eye morphogenesis	3	18	16.6666666666667	0.0095856904108248	0.0455890157210691	1	1	0.966677194664984	0.999148947208221	0.402099840942968
down	BMP7; GJC1; TBX2;	GO:0048738~cardiac muscle tissue development	3	18	16.6666666666667	0.0095856904108248	0.0455890157210691	1	1	0.966677194664984	0.999148947208221	0.402099840942968
down	LRP6; AACS; SMO;	GO:0071397~cellular response to cholesterol	3	18	16.6666666666667	0.0095856904108248	0.0455890157210691	1	1	0.966677194664984	0.999148947208221	0.402099840942968
down	DLL1; FGF1; FUT1;	GO:1903672~positive regulation of sprouting angiogenesis	3	18	16.6666666666667	0.0095856904108248	0.0455890157210691	1	1	0.966677194664984	0.999148947208221	0.402099840942968
down	ARL4D; LTBP2; STEAP3; RAB3B; RAB13;	GO:0009306~protein secretion	5	56	8.92857142857143	0.0096101170179288	0.04559106700141	1	1	0.966677194664984	0.999148947208221	0.402117933448054
down	DLL1; SOX9; LAMB2; LAMC3; RP1;	GO:0060041~retina development in camera-type eye	5	56	8.92857142857143	0.0096101170179288	0.04559106700141	1	1	0.966677194664984	0.999148947208221	0.402117933448054
up	OSM; FLT3; IL18; IL23A;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	4	69	5.79710144927536	0.0100870261927386	0.0786958288201421	1	1	0.982323498149493	0.982323498149493	0.637427264810999
up	ANXA9; CSTA; ICAM3; DSG1; PKP1; ICOS;	GO:0098609~cell-cell adhesion	6	152	3.94736842105263	0.0102187393493969	0.0793884414161127	1	1	0.982323498149493	0.982323498149493	0.643037348080243
down	LDLR; ANXA1; AXL; ELMO3; TYRO3;	GO:0006909~phagocytosis	5	57	8.7719298245614	0.0102742890964448	0.0484997497720375	1	1	0.974979802086657	0.999148947208221	0.42777281677738
down	GPR143; NCS1; PLCB4; PIK3C2G; PLCD3;	GO:0048015~phosphatidylinositol-mediated signaling	5	57	8.7719298245614	0.0102742890964448	0.0484997497720375	1	1	0.974979802086657	0.999148947208221	0.42777281677738
down	BMP4; ITGA2; FGFR2; CDH13; CX3CL1;	GO:0048661~positive regulation of smooth muscle cell proliferation	5	57	8.7719298245614	0.0102742890964448	0.0484997497720375	1	1	0.974979802086657	0.999148947208221	0.42777281677738
down	SDC1; CCND1; SLC6A1; CAV1; AQP3;	GO:0051592~response to calcium ion	5	57	8.7719298245614	0.0102742890964448	0.0484997497720375	1	1	0.974979802086657	0.999148947208221	0.42777281677738
down	BMP4; ETV5; NBL1; FOXA1; IRX3; DUOXA1;	GO:0045666~positive regulation of neuron differentiation	6	81	7.40740740740741	0.0107351537851816	0.0506123875728167	1	1	0.979598127464962	0.999148947208221	0.446406501015288
up	IL18RAP; LTF; S100A8; CD40LG; S100A12; IL18;	GO:0051092~positive regulation of NF-kappaB transcription factor activity	6	154	3.8961038961039	0.0108259371260901	0.0820434602244118	1	1	0.982323498149493	0.982323498149493	0.664542698520909
up	CLIC3; SLC26A9; NMUR1;	GO:0006821~chloride transport	3	37	8.10810810810811	0.0109025034142937	0.0820434602244118	1	1	0.982323498149493	0.982323498149493	0.664542698520909
up	HP; ASS1; ORM1;	GO:0006953~acute-phase response	3	37	8.10810810810811	0.0109025034142937	0.0820434602244118	1	1	0.982323498149493	0.982323498149493	0.664542698520909
down	DLX2; OSR1; DLG2;	GO:0009790~embryo development	3	19	15.7894736842105	0.01092609201476	0.051069064767636	1	1	0.982331941830913	0.999148947208221	0.45043444117795
down	APOE; PLTP; CAV1;	GO:0010875~positive regulation of cholesterol efflux	3	19	15.7894736842105	0.01092609201476	0.051069064767636	1	1	0.982331941830913	0.999148947208221	0.45043444117795
down	MYO1D; MYO1B; MYO1C;	GO:0030050~vesicle transport along actin filament	3	19	15.7894736842105	0.01092609201476	0.051069064767636	1	1	0.982331941830913	0.999148947208221	0.45043444117795
down	TBX3; DHCR24; LGR4;	GO:0030539~male genitalia development	3	19	15.7894736842105	0.01092609201476	0.051069064767636	1	1	0.982331941830913	0.999148947208221	0.45043444117795
down	GLI3; SOX9; LOXL2;	GO:0032332~positive regulation of chondrocyte differentiation	3	19	15.7894736842105	0.01092609201476	0.051069064767636	1	1	0.982331941830913	0.999148947208221	0.45043444117795
down	APOE; RHBDF1; FRMD4A;	GO:0050709~negative regulation of protein secretion	3	19	15.7894736842105	0.01092609201476	0.051069064767636	1	1	0.982331941830913	0.999148947208221	0.45043444117795
down	TERT; HMGA2; PLK2;	GO:2000773~negative regulation of cellular senescence	3	19	15.7894736842105	0.01092609201476	0.051069064767636	1	1	0.982331941830913	0.999148947208221	0.45043444117795
down	GJB3; DCN; ETNK2; PHLDA2;	GO:0001890~placenta development	4	37	10.8108108108108	0.0110399005031643	0.0512856013594429	1	1	0.982551144781621	0.999148947208221	0.452344316347368
down	FXYD3; ANO4; ANO1; WNK4;	GO:0006821~chloride transport	4	37	10.8108108108108	0.0110399005031643	0.0512856013594429	1	1	0.982551144781621	0.999148947208221	0.452344316347368
down	EDIL3; PTN; EGFLAM; EGFL6;	GO:0010811~positive regulation of cell-substrate adhesion	4	37	10.8108108108108	0.0110399005031643	0.0512856013594429	1	1	0.982551144781621	0.999148947208221	0.452344316347368
down	CLDN7; CRYAB; ISL1; STXBP1;	GO:0031333~negative regulation of protein-containing complex assembly	4	37	10.8108108108108	0.0110399005031643	0.0512856013594429	1	1	0.982551144781621	0.999148947208221	0.452344316347368
down	AXL; HES1; EPAS1; LHX6;	GO:0048469~cell maturation	4	37	10.8108108108108	0.0110399005031643	0.0512856013594429	1	1	0.982551144781621	0.999148947208221	0.452344316347368
up	EREG; IL2RA; FLT3; CCR5; IL5RA; IL18; ANGPT1; EPGN;	GO:0000165~MAPK cascade	8	254	3.1496062992126	0.0114863941492324	0.0856384789593977	1	1	0.982323498149493	0.982323498149493	0.693661941478801
up	TYROBP; C1QA; FCGR2B;	GO:1901216~positive regulation of neuron death	3	38	7.89473684210526	0.0116644115120799	0.0866164533567697	1	1	0.982323498149493	0.982323498149493	0.701583422890437
down	DLL1; TBX1; NKX3-2; DNAH5; PITX2;	GO:0007368~determination of left/right symmetry	5	59	8.47457627118644	0.0116955111589607	0.0518587425951584	1	1	0.989608474733365	0.999148947208221	0.457399481414522
down	INHA; KITLG; FOXL2; MMP19;	GO:0001541~ovarian follicle development	4	38	10.5263157894737	0.0120008185509146	0.0530886036012521	1	1	0.992798187786494	0.999148947208221	0.468246982881935
down	TF; WNT5A; WNT7B; DAB2IP;	GO:0007257~activation of JUN kinase activity	4	38	10.5263157894737	0.0120008185509146	0.0530886036012521	1	1	0.992798187786494	0.999148947208221	0.468246982881935
down	TNFRSF21; SEMA5A; NDN;	GO:0007413~axonal fasciculation	3	20	15	0.0123692407102063	0.0545279752886124	1	1	0.996167602983461	0.999148947208221	0.480942390260031
down	SPR; CAV1; CYGB;	GO:0050999~regulation of nitric-oxide synthase activity	3	20	15	0.0123692407102063	0.0545279752886124	1	1	0.996167602983461	0.999148947208221	0.480942390260031
down	NRP2; WNT5A; SEMA3F;	GO:0099175~regulation of postsynapse organization	3	20	15	0.0123692407102063	0.0545279752886124	1	1	0.996167602983461	0.999148947208221	0.480942390260031
down	HRH1; P2RY1; ANO1; ADRA1D; ADRA1B;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	5	60	8.33333333333333	0.0124538027682527	0.0547736695825929	1	1	0.996304221460216	0.999148947208221	0.483109439382886
down	GXYLT2; GALNT5; MUC20; GALNT14; MUC4;	GO:0016266~O-glycan processing	5	60	8.33333333333333	0.0124538027682527	0.0547736695825929	1	1	0.996304221460216	0.999148947208221	0.483109439382886
up	ATP10A; S100B; VIL1; EPB42; PALMD; RND3;	GO:0008360~regulation of cell shape	6	159	3.77358490566038	0.0124548693768927	0.0902946757634506	1	1	0.982323498149493	0.982323498149493	0.731376606127831
up	TRPM2; CCR5; RYR2; NMUR1;	GO:0006816~calcium ion transport	4	74	5.40540540540541	0.0126423708261859	0.0906036575876657	1	1	0.982323498149493	0.982323498149493	0.733879323769142
down	ANXA8; LAPTM4B; SNX33; ANXA8L1;	GO:0007032~endosome organization	4	39	10.2564102564103	0.0130136999992516	0.0571039953777785	1	1	0.999148947208221	0.999148947208221	0.503663154280406
down	LRP5; LRP6; SLC7A8; ANTXR1;	GO:1901998~toxin transport	4	39	10.2564102564103	0.0130136999992516	0.0571039953777785	1	1	0.999148947208221	0.999148947208221	0.503663154280406
up	FLT4; SLAMF1; ANGPT1; SCIMP; GPR55; XCL1; XCL2;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	7	209	3.34928229665072	0.0130161299858396	0.0929221017135805	1	1	0.982323498149493	0.982323498149493	0.752658457554956
down	FAM83G; BMP4; BMP7; FSTL1; SOSTDC1; TMEM100;	GO:0030509~BMP signaling pathway	6	85	7.05882352941176	0.0132039331289537	0.0578719099077557	1	1	0.999148947208221	0.999148947208221	0.510436239978304
down	SOX15; SOX2; HMGA2; CBX2; HDAC11; ZNF462; PADI3; FOXA2;	GO:0006325~chromatin organization	8	139	5.75539568345324	0.0137083727280676	0.0600136133256415	1	1	0.999148947208221	0.999148947208221	0.529326285969819
down	YAP1; SOX9; WWTR1;	GO:0001894~tissue homeostasis	3	21	14.2857142857143	0.0139162856422205	0.0602986150974205	1	1	0.999148947208221	0.999148947208221	0.531840031118474
down	KDR; EFNB2; ROBO1;	GO:0002042~cell migration involved in sprouting angiogenesis	3	21	14.2857142857143	0.0139162856422205	0.0602986150974205	1	1	0.999148947208221	0.999148947208221	0.531840031118474
down	PLPP3; PLPP2; FUT6;	GO:0006672~ceramide metabolic process	3	21	14.2857142857143	0.0139162856422205	0.0602986150974205	1	1	0.999148947208221	0.999148947208221	0.531840031118474
down	CLDN7; CLDN14; CLDN12;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	3	21	14.2857142857143	0.0139162856422205	0.0602986150974205	1	1	0.999148947208221	0.999148947208221	0.531840031118474
down	GLI3; OCA2; TYRP1;	GO:0030318~melanocyte differentiation	3	21	14.2857142857143	0.0139162856422205	0.0602986150974205	1	1	0.999148947208221	0.999148947208221	0.531840031118474
down	CXADR; MARVELD2; MARVELD3;	GO:0045216~cell-cell junction organization	3	21	14.2857142857143	0.0139162856422205	0.0602986150974205	1	1	0.999148947208221	0.999148947208221	0.531840031118474
down	LRP4; NGFR; EFNB3;	GO:0050771~negative regulation of axonogenesis	3	21	14.2857142857143	0.0139162856422205	0.0602986150974205	1	1	0.999148947208221	0.999148947208221	0.531840031118474
down	HS6ST1; HES1; PLCD3;	GO:0060716~labyrinthine layer blood vessel development	3	21	14.2857142857143	0.0139162856422205	0.0602986150974205	1	1	0.999148947208221	0.999148947208221	0.531840031118474
down	SHANK2; SHANK3; SHISA9;	GO:2000311~regulation of AMPA receptor activity	3	21	14.2857142857143	0.0139162856422205	0.0602986150974205	1	1	0.999148947208221	0.999148947208221	0.531840031118474
down	ITGA2; MCC; PLK1; DZIP1;	GO:0045184~establishment of protein localization	4	40	10	0.0140794479642106	0.060936107362187	1	1	0.999148947208221	0.999148947208221	0.537462778927581
down	C1R; C3; CFI; CFH; C1S; CD59; SUSD4;	GO:0030449~regulation of complement activation	7	113	6.19469026548673	0.0144944870303444	0.0613055534621291	1	1	0.999148947208221	0.999148947208221	0.540721331797698
down	DSCAM; B4GALT2; ETV5; NAV2; RASD2; PAK6;	GO:0007626~locomotory behavior	6	87	6.89655172413793	0.0145762120794899	0.0613055534621291	1	1	0.999148947208221	0.999148947208221	0.540721331797698
down	NQO1; IGFBP2; ALDH3A1; AACS; LIPG;	GO:0007584~response to nutrient	5	63	7.93650793650794	0.0149265223430046	0.0619899288561941	1	1	0.999148947208221	0.999148947208221	0.54675759366355
down	BAG3; FGF1; HSPA1B; ANO1; SLC52A3;	GO:0034605~cellular response to heat	5	63	7.93650793650794	0.0149265223430046	0.0619899288561941	1	1	0.999148947208221	0.999148947208221	0.54675759366355
up	TRIM16; SPI1; IRF4;	GO:0043966~histone H3 acetylation	3	42	7.14285714285714	0.0150126116025665	0.102808588344983	1	1	0.982323498149493	0.982323498149493	0.83273787506066
down	PDPN; SLC38A4; SLC6A15; SLC7A8;	GO:0006865~amino acid transport	4	41	9.75609756097561	0.0151989131984241	0.062983500713208	1	1	0.999148947208221	0.999148947208221	0.555521000360354
down	NGFR; GJA1; VCAM1; LGMN;	GO:1904646~cellular response to amyloid-beta	4	41	9.75609756097561	0.0151989131984241	0.062983500713208	1	1	0.999148947208221	0.999148947208221	0.555521000360354
up	CGNL1; PACSIN1; MYO5B; RND3; MYO7B;	GO:0007015~actin filament organization	5	121	4.13223140495868	0.0155168186711907	0.103604684668389	1	1	0.982323498149493	0.982323498149493	0.839186164754824
down	CAV2; BVES; NDRG4;	GO:0048278~vesicle docking	3	22	13.6363636363636	0.0155681509839962	0.0644433265132741	1	1	0.999148947208221	0.999148947208221	0.56839681513123
up	CLDN5; DSG1; PKP1;	GO:0007043~cell-cell junction assembly	3	43	6.97674418604651	0.015925512516568	0.103604684668389	1	1	0.982323498149493	0.982323498149493	0.839186164754824
up	VIL1; FOXC1; SKAP1;	GO:0071364~cellular response to epidermal growth factor stimulus	3	43	6.97674418604651	0.015925512516568	0.103604684668389	1	1	0.982323498149493	0.982323498149493	0.839186164754824
down	INHA; BMP4; HPGD; BMP7;	GO:0045786~negative regulation of cell cycle	4	42	9.52380952380952	0.0163728939085158	0.0676271704916958	1	1	0.999148947208221	0.999148947208221	0.596478648815542
down	ADH7; LYPD6; PCSK9; DKK3;	GO:2000272~negative regulation of signaling receptor activity	4	42	9.52380952380952	0.0163728939085158	0.0676271704916958	1	1	0.999148947208221	0.999148947208221	0.596478648815542
down	APOD; PLTP; SLCO2A1; CAV2; CAV1;	GO:0006869~lipid transport	5	65	7.69230769230769	0.0167454778078229	0.069091005070279	1	1	0.999148947208221	0.999148947208221	0.609389821428183
up	FCGR2B; FLT4; SLAMF1; SEMA3A;	GO:0046330~positive regulation of JNK cascade	4	81	4.93827160493827	0.016861445083552	0.103604684668389	1	1	0.982323498149493	0.982323498149493	0.839186164754824
down	OBSL1; CAV2; PKMYT1;	GO:0007088~regulation of mitotic nuclear division	3	23	13.0434782608696	0.0173255477167643	0.0709451307367504	1	1	0.999148947208221	0.999148947208221	0.625743401863829
down	CYP7B1; CYP11A1; CYP39A1;	GO:0016125~sterol metabolic process	3	23	13.0434782608696	0.0173255477167643	0.0709451307367504	1	1	0.999148947208221	0.999148947208221	0.625743401863829
down	VCAM1; KDR; GPR143;	GO:0035584~calcium-mediated signaling using intracellular calcium source	3	23	13.0434782608696	0.0173255477167643	0.0709451307367504	1	1	0.999148947208221	0.999148947208221	0.625743401863829
down	DLL1; APOE; WNT5A;	GO:0045807~positive regulation of endocytosis	3	23	13.0434782608696	0.0173255477167643	0.0709451307367504	1	1	0.999148947208221	0.999148947208221	0.625743401863829
down	ANXA1; STC1; ISL1;	GO:0071385~cellular response to glucocorticoid stimulus	3	23	13.0434782608696	0.0173255477167643	0.0709451307367504	1	1	0.999148947208221	0.999148947208221	0.625743401863829
down	TBX3; HRAS; TBX2;	GO:0090398~cellular senescence	3	23	13.0434782608696	0.0173255477167643	0.0709451307367504	1	1	0.999148947208221	0.999148947208221	0.625743401863829
up	ASS1; TCL1A; OCLN; XCL2; XCL1;	GO:0071356~cellular response to tumor necrosis factor	5	125	4	0.0175287795390819	0.103604684668389	1	1	0.982323498149493	0.982323498149493	0.839186164754824
down	TBX3; TBX1; ANTXR1; DHCR7;	GO:0001568~blood vessel development	4	43	9.30232558139535	0.0176021356856984	0.071563333034096	1	1	0.999148947208221	0.999148947208221	0.631196010162155
down	MMP2; MMP10; MMP19; MMP16;	GO:0030574~collagen catabolic process	4	43	9.30232558139535	0.0176021356856984	0.071563333034096	1	1	0.999148947208221	0.999148947208221	0.631196010162155
up	S100A8; TLR8; TLR7;	GO:0002224~toll-like receptor signaling pathway	3	45	6.66666666666667	0.017843079967425	0.103604684668389	1	1	0.982323498149493	0.982323498149493	0.839186164754824
up	FCGR2B; LYAR; SIRPG;	GO:0050766~positive regulation of phagocytosis	3	45	6.66666666666667	0.017843079967425	0.103604684668389	1	1	0.982323498149493	0.982323498149493	0.839186164754824
down	SPRY2; PSCA; FBLN1; DAB2IP; SPRY4;	GO:0070373~negative regulation of ERK1 and ERK2 cascade	5	67	7.46268656716418	0.0187057201338883	0.0736598305790419	1	1	0.999148947208221	0.999148947208221	0.649687335671745
up	GJB6; C1QB; KCNQ1;	GO:0048839~inner ear development	3	46	6.52173913043478	0.0188478920246278	0.103604684668389	1	1	0.982323498149493	0.982323498149493	0.839186164754824
down	SOX9; FOXA2; ANXA1;	GO:0031018~endocrine pancreas development	3	24	12.5	0.0191889849530869	0.0754846198982713	1	1	0.999148947208221	0.999148947208221	0.665782166485946
down	APOE; ISL1; TYRO3; CXCL17; FNDC4; WFDC1;	GO:0050728~negative regulation of inflammatory response	6	93	6.45161290322581	0.0192812474452086	0.0757691212945118	1	1	0.999148947208221	0.999148947208221	0.66829149827052
down	KCNJ5; FXYD3; KCNS3; KCNF1; KCNS2;	GO:0006813~potassium ion transport	5	68	7.35294117647059	0.0197400473777696	0.0774919215243021	1	1	0.999148947208221	0.999148947208221	0.683486774751452
up	CEACAM8; CEACAM6; NECTIN4;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	3	47	6.38297872340426	0.0198834601133677	0.103604684668389	1	1	0.982323498149493	0.982323498149493	0.839186164754824
down	EPHA2; SFN; BCL2L10; BOK;	GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage	4	45	8.88888888888889	0.0202291220318553	0.0793298903210013	1	1	0.999148947208221	0.999148947208221	0.699697849922118
down	PIK3C2G; CXCL14; PLAU; HRAS; FOSL1; CX3CL1; CCL26;	GO:0006935~chemotaxis	7	122	5.73770491803279	0.0207276950647415	0.0812012796350697	1	1	0.999148947208221	0.999148947208221	0.716203697517803
down	MDK; NTRK2; SMO; GNG12; LRP6;	GO:0021987~cerebral cortex development	5	69	7.2463768115942	0.0208111270377336	0.0814441634844363	1	1	0.999148947208221	0.999148947208221	0.718345958228046
up	S100A8; FASLG; P2RX1; FAM162A;	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	4	87	4.59770114942529	0.0211024044847711	0.103604684668389	1	1	0.982323498149493	0.982323498149493	0.839186164754824
up	PFKFB2; ACP7; SGPP2; NT5C3A;	GO:0016311~dephosphorylation	4	87	4.59770114942529	0.0211024044847711	0.103604684668389	1	1	0.982323498149493	0.982323498149493	0.839186164754824
down	NOS1; CYP2J2; CYP2E1;	GO:0042738~exogenous drug catabolic process	3	25	12	0.0211587808188851	0.0826344985732409	1	1	0.999148947208221	0.999148947208221	0.728844837010726
down	FGFR2; YAP1; TBX2;	GO:0060045~positive regulation of cardiac muscle cell proliferation	3	25	12	0.0211587808188851	0.0826344985732409	1	1	0.999148947208221	0.999148947208221	0.728844837010726
down	BMP4; VEGFC; CX3CL1; SEMA5A;	GO:0050918~positive chemotaxis	4	46	8.69565217391304	0.0216280954958833	0.0828924847389797	1	1	0.999148947208221	0.999148947208221	0.731120301715728
down	GJA1; FGFR2; STC1; SULF1;	GO:0060348~bone development	4	46	8.69565217391304	0.0216280954958833	0.0828924847389797	1	1	0.999148947208221	0.999148947208221	0.731120301715728
down	PCDH7; TF; VEGFC; STXBP1; LGALS3BP; ECM1; CD109;	GO:0002576~platelet degranulation	7	124	5.64516129032258	0.0223316333455414	0.0845221182400971	1	1	0.999148947208221	0.999148947208221	0.745493837999201
up	EREG; CD3D; ADRB2; CD3G; EPGN;	GO:0061024~membrane organization	5	134	3.73134328358209	0.0226673588347821	0.103604684668389	1	1	0.982323498149493	0.982323498149493	0.839186164754824
down	CDH1; NQO1; SLC6A1; DHRS2; SLC7A8;	GO:0009636~response to toxic substance	5	71	7.04225352112676	0.0230652733887267	0.0870259878239115	1	1	0.999148947208221	0.999148947208221	0.767578227088751
down	CDH11; GRIK2; PLCB4; NTNG1; NTF4;	GO:0050804~modulation of chemical synaptic transmission	5	71	7.04225352112676	0.0230652733887267	0.0870259878239115	1	1	0.999148947208221	0.999148947208221	0.767578227088751
down	WNT5A; NBL1; SOSTDC1; SFRP1;	GO:0030514~negative regulation of BMP signaling pathway	4	47	8.51063829787234	0.0230847883490797	0.0870259878239115	1	1	0.999148947208221	0.999148947208221	0.767578227088751
down	HS6ST1; CTF1; TENM3; TENM2;	GO:0048666~neuron development	4	47	8.51063829787234	0.0230847883490797	0.0870259878239115	1	1	0.999148947208221	0.999148947208221	0.767578227088751
up	EREG; VIL1; EPGN;	GO:0007173~epidermal growth factor receptor signaling pathway	3	50	6	0.0231749636290211	0.104513433536732	1	1	0.982323498149493	0.982323498149493	0.84654692725307
up	TRPM2; XCL1; RYR2;	GO:0051209~release of sequestered calcium ion into cytosol	3	50	6	0.0231749636290211	0.104513433536732	1	1	0.982323498149493	0.982323498149493	0.84654692725307
down	GJB3; TRIP10; FRAS1;	GO:0007154~cell communication	3	26	11.5384615384615	0.0232350729085881	0.0872463211982556	1	1	0.999148947208221	0.999148947208221	0.769521590273432
down	APOE; NQO1; CHRNG;	GO:0007271~synaptic transmission, cholinergic	3	26	11.5384615384615	0.0232350729085881	0.0872463211982556	1	1	0.999148947208221	0.999148947208221	0.769521590273432
down	SNAI2; VANGL1; TYRP1;	GO:0043473~pigmentation	3	26	11.5384615384615	0.0232350729085881	0.0872463211982556	1	1	0.999148947208221	0.999148947208221	0.769521590273432
down	ADCY6; GJB2; CPS1;	GO:0071377~cellular response to glucagon stimulus	3	26	11.5384615384615	0.0232350729085881	0.0872463211982556	1	1	0.999148947208221	0.999148947208221	0.769521590273432
up	FUT3; FUT7; ST6GALNAC5; B3GNT3;	GO:0006486~protein glycosylation	4	90	4.44444444444444	0.0234463150353251	0.105479894161353	1	1	0.982323498149493	0.982323498149493	0.854375148414678
down	WNT9A; CRYAB; NGFR; SFN; DHCR24;	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	5	72	6.94444444444444	0.0242491560652085	0.0909642576977219	1	1	0.999148947208221	0.999148947208221	0.802314175316688
up	LTF; ADRB2; TCL1A;	GO:0071902~positive regulation of protein serine/threonine kinase activity	3	51	5.88235294117647	0.0243337466700674	0.107638989456829	1	1	0.982323498149493	0.982323498149493	0.871863574793755
down	NTF4; GDNF; SLITRK6; FOXA2;	GO:0008344~adult locomotory behavior	4	48	8.33333333333333	0.0245996854775284	0.0920973446449341	1	1	0.999148947208221	0.999148947208221	0.812308119560542
down	BMP4; BMP7; RBPMS; INHA;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	4	48	8.33333333333333	0.0245996854775284	0.0920973446449341	1	1	0.999148947208221	0.999148947208221	0.812308119560542
down	TAX1BP3; EPHA2; WNT5A; ARHGEF16; SYDE1; TBC1D8B;	GO:0090630~activation of GTPase activity	6	99	6.06060606060606	0.0249270648890123	0.0932311482069358	1	1	0.999148947208221	0.999148947208221	0.82230838442107
up	GJB6; S100A8; ELANE; CNR2; FASLG;	GO:0032496~response to lipopolysaccharide	5	138	3.6231884057971	0.0252331938019619	0.111351253794338	1	1	0.982323498149493	0.982323498149493	0.90193249379989
down	ECM1; AMTN; FAM83H;	GO:0031214~biomineral tissue development	3	27	11.1111111111111	0.0254178283290236	0.0941435857711773	1	1	0.999148947208221	0.999148947208221	0.830356178251423
down	MECOM; SH3RF2; MARVELD3;	GO:0046329~negative regulation of JNK cascade	3	27	11.1111111111111	0.0254178283290236	0.0941435857711773	1	1	0.999148947208221	0.999148947208221	0.830356178251423
down	NGFR; PLK1; CARD10;	GO:1900182~positive regulation of protein localization to nucleus	3	27	11.1111111111111	0.0254178283290236	0.0941435857711773	1	1	0.999148947208221	0.999148947208221	0.830356178251423
down	NTN1; HRAS; DHCR24; CNKSR1; PLK2;	GO:0007265~Ras protein signal transduction	5	73	6.84931506849315	0.0254714227122148	0.0941435857711773	1	1	0.999148947208221	0.999148947208221	0.830356178251423
up	CERS3; SGPP2; ELOVL4;	GO:0030148~sphingolipid biosynthetic process	3	52	5.76923076923077	0.0255233104585184	0.112363335804287	1	1	0.982323498149493	0.982323498149493	0.910130242994969
up	IL2RA; ELANE; PTPN2; CNR2;	GO:0050728~negative regulation of inflammatory response	4	93	4.3010752688172	0.025942046494778	0.113935496363051	1	1	0.982323498149493	0.982323498149493	0.922864564747997
down	GJA1; WNT5A; SOX9; DAB2IP; PLK2;	GO:0045732~positive regulation of protein catabolic process	5	74	6.75675675675676	0.02673243152556	0.0971159080278472	1	1	0.999148947208221	0.999148947208221	0.856572368439663
up	CD3G; RND3; PARVG;	GO:0007163~establishment or maintenance of cell polarity	3	53	5.66037735849057	0.0267436190295476	0.116315119287098	1	1	0.982323498149493	0.982323498149493	0.942139239841934
up	CTLA4; CD40LG; ICOS;	GO:0031295~T cell costimulation	3	53	5.66037735849057	0.0267436190295476	0.116315119287098	1	1	0.982323498149493	0.982323498149493	0.942139239841934
up	OVOL1; UPK3A; ASS1; FOXC1;	GO:0001822~kidney development	4	94	4.25531914893617	0.0268080017173086	0.116315119287098	1	1	0.982323498149493	0.982323498149493	0.942139239841934
down	GPX3; PXDN; DUOX1;	GO:0042744~hydrogen peroxide catabolic process	3	28	10.7142857142857	0.0277068533445972	0.100368010209218	1	1	0.999148947208221	0.999148947208221	0.885256246544429
down	COBL; FGFR2; LGR4;	GO:0048565~digestive tract development	3	28	10.7142857142857	0.0277068533445972	0.100368010209218	1	1	0.999148947208221	0.999148947208221	0.885256246544429
down	TERT; TK1; LOX;	GO:0071897~DNA biosynthetic process	3	28	10.7142857142857	0.0277068533445972	0.100368010209218	1	1	0.999148947208221	0.999148947208221	0.885256246544429
down	CRYAB; FOSL1; AREG; SDC1;	GO:0042542~response to hydrogen peroxide	4	50	8	0.0278057772823501	0.100630432069458	1	1	0.999148947208221	0.999148947208221	0.887570834534395
down	FZD6; GNA11; P2RY1; TYRO3; PDPN; AXL;	GO:0030168~platelet activation	6	102	5.88235294117647	0.0281238433046385	0.101684685592413	1	1	0.999148947208221	0.999148947208221	0.896869459810441
up	GJB6; KCNQ1; GRAP; USH1G; MYO7B;	GO:0007605~sensory perception of sound	5	143	3.4965034965035	0.0286926490596691	0.116315119287098	1	1	0.982323498149493	0.982323498149493	0.942139239841934
up	TAL1; WNT1; GATA1;	GO:0045165~cell fate commitment	3	55	5.45454545454545	0.0292762637864186	0.116315119287098	1	1	0.982323498149493	0.982323498149493	0.942139239841934
up	ATP2C2; SKAP1; TESC; PACSIN1; EFR3B;	GO:0072659~protein localization to plasma membrane	5	144	3.47222222222222	0.0294186823773727	0.116315119287098	1	1	0.982323498149493	0.982323498149493	0.942139239841934
down	PLK1; ESPL1; SNX33; RTKN;	GO:0000281~mitotic cytokinesis	4	51	7.84313725490196	0.0294976885571334	0.106348402767654	1	1	0.999148947208221	0.999148947208221	0.938003928381575
down	TBX1; GAD1; SHANK3; SHANK2;	GO:0035176~social behavior	4	51	7.84313725490196	0.0294976885571334	0.106348402767654	1	1	0.999148947208221	0.999148947208221	0.938003928381575
down	COL4A1; COL5A2; MMP2; NTRK2;	GO:0071230~cellular response to amino acid stimulus	4	51	7.84313725490196	0.0294976885571334	0.106348402767654	1	1	0.999148947208221	0.999148947208221	0.938003928381575
down	NCS1; SFRP1; MARK1;	GO:0010975~regulation of neuron projection development	3	29	10.3448275862069	0.0301018026377461	0.106751626044042	1	1	0.999148947208221	0.999148947208221	0.941560399446715
down	SCIN; SYT12; SYT8;	GO:0017156~calcium-ion regulated exocytosis	3	29	10.3448275862069	0.0301018026377461	0.106751626044042	1	1	0.999148947208221	0.999148947208221	0.941560399446715
down	B4GALT2; PRELP; FMOD;	GO:0018146~keratan sulfate biosynthetic process	3	29	10.3448275862069	0.0301018026377461	0.106751626044042	1	1	0.999148947208221	0.999148947208221	0.941560399446715
down	RAB13; EPB41L1; EHD2;	GO:0030866~cortical actin cytoskeleton organization	3	29	10.3448275862069	0.0301018026377461	0.106751626044042	1	1	0.999148947208221	0.999148947208221	0.941560399446715
down	NFASC; VCAM1; PARVA;	GO:0034113~heterotypic cell-cell adhesion	3	29	10.3448275862069	0.0301018026377461	0.106751626044042	1	1	0.999148947208221	0.999148947208221	0.941560399446715
up	HLA-DQA2; HLA-DQB2; HLA-DMB; FCGR2B;	GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II	4	98	4.08163265306122	0.0304434912248349	0.116315119287098	1	1	0.982323498149493	0.982323498149493	0.942139239841934
down	SCNN1B; FXYD3; SLC4A11; SLC38A4; SLC6A15;	GO:0006814~sodium ion transport	5	77	6.49350649350649	0.0307511892532211	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	BMP4; BMP7; NR2F2; HNF4G;	GO:0043401~steroid hormone mediated signaling pathway	4	52	7.69230769230769	0.0312492385439954	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	TFAP2A; NQO1; GRIK2; PCSK9;	GO:0043525~positive regulation of neuron apoptotic process	4	52	7.69230769230769	0.0312492385439954	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	ARHGEF5; SFRP1; NOX4; LIMCH1;	GO:0051496~positive regulation of stress fiber assembly	4	52	7.69230769230769	0.0312492385439954	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	KCTD11; KCTD1; KCNS3; KCNF1; EHD3; KCNS2;	GO:0051260~protein homooligomerization	6	105	5.71428571428571	0.0315796150264415	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	CCNO; PLK1; CDH13; PKMYT1; FBXL7; TUBB6; PLK2;	GO:0000278~mitotic cell cycle	7	134	5.22388059701492	0.0316431041031101	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	ANXA1; WNT5A; DUOXA1; DUOXA2; IL1RL2;	GO:0050727~regulation of inflammatory response	5	78	6.41025641025641	0.0321703430992815	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	TBX1; IRX3; FOXC2;	GO:0007498~mesoderm development	3	30	10	0.0326021881981284	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	PRSS3; UCN2; CYP39A1;	GO:0007586~digestion	3	30	10	0.0326021881981284	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	RNF180; SHANK3; SHANK2;	GO:0030534~adult behavior	3	30	10	0.0326021881981284	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	PTN; GRIK2; DLG2;	GO:0043113~receptor clustering	3	30	10	0.0326021881981284	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	ITGA2; ISL1; HES1;	GO:0043388~positive regulation of DNA binding	3	30	10	0.0326021881981284	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	BCAR1; CSPG4; PLAT;	GO:0048008~platelet-derived growth factor receptor signaling pathway	3	30	10	0.0326021881981284	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	PTN; MDK; TRIP13;	GO:0048477~oogenesis	3	30	10	0.0326021881981284	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	TF; KDR; SOX9;	GO:0070371~ERK1 and ERK2 cascade	3	30	10	0.0326021881981284	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	FOSL1; ADORA2B; LGALS3BP; IL1RL2;	GO:0006968~cellular defense response	4	53	7.54716981132075	0.0330606626662719	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	BDKRB1; P2RY1; DLG2; NDN;	GO:0019233~sensory perception of pain	4	53	7.54716981132075	0.0330606626662719	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	NPR1; NOS1; FXYD3; EHD3;	GO:1903779~regulation of cardiac conduction	4	53	7.54716981132075	0.0330606626662719	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	CHEK1; BAG3; ITGA2; GJA1; SOX9;	GO:0071260~cellular response to mechanical stimulus	5	79	6.32911392405063	0.0336297251379911	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
up	S100B; PTPRZ1; LILRB2;	GO:0007611~learning or memory	3	59	5.08474576271187	0.0347075522663497	0.118184648509172	1	1	0.982323498149493	0.982323498149493	0.957282213953496
down	IGFBP5; CPS1; STC1; NOX4;	GO:0071320~cellular response to cAMP	4	54	7.40740740740741	0.0349321484994241	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	IRX5; BVES; EPAS1;	GO:0002027~regulation of heart rate	3	31	9.67741935483871	0.0352073878526156	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	ACOT7; ACOT11; ACSM4;	GO:0006637~acyl-CoA metabolic process	3	31	9.67741935483871	0.0352073878526156	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	EDNRA; NTF4; NTRK2;	GO:0007202~activation of phospholipase C activity	3	31	9.67741935483871	0.0352073878526156	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	KDR; DDR1; FRK;	GO:0038083~peptidyl-tyrosine autophosphorylation	3	31	9.67741935483871	0.0352073878526156	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	MEIS2; FOXA1; LGMN;	GO:0045931~positive regulation of mitotic cell cycle	3	31	9.67741935483871	0.0352073878526156	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	GLI3; CCND1; PTPN3;	GO:0097421~liver regeneration	3	31	9.67741935483871	0.0352073878526156	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	PLCB4; ASPG; PLCD3; PNLIPRP3; LIPG;	GO:0016042~lipid catabolic process	5	81	6.17283950617284	0.0366700962164888	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	HRAS; DAB2IP; SH3RF2; WNT7B; TNFRSF19;	GO:0046330~positive regulation of JNK cascade	5	81	6.17283950617284	0.0366700962164888	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	SFN; PKMYT1; CCND1; CCNO;	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity	4	55	7.27272727272727	0.0368638365669851	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	PLK1; CAPN6; NCKAP5;	GO:0001578~microtubule bundle formation	3	32	9.375	0.0379166534488544	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	SLC6A15; SLC6A17; SLC6A1;	GO:0006810~transport	3	32	9.375	0.0379166534488544	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	DLL1; BAG3; PTN;	GO:0021510~spinal cord development	3	32	9.375	0.0379166534488544	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	SNAI2; NET1; TNKS1BP1;	GO:0071479~cellular response to ionizing radiation	3	32	9.375	0.0379166534488544	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	KCNK2; HES1; SLITRK6;	GO:0090102~cochlea development	3	32	9.375	0.0379166534488544	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	TERT; ANXA1; CCND1;	GO:1900087~positive regulation of G1/S transition of mitotic cell cycle	3	32	9.375	0.0379166534488544	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
up	ATP10A; ATP2C2; ATP12A; ATP13A4; ATP6V1C2; RYR2;	GO:0034220~ion transmembrane transport	6	208	2.88461538461538	0.0381994818125531	0.1279883535054	1	1	0.982323498149493	0.982323498149493	1
down	RASAL1; WNT5A; LGMN; SYT12; SYT8;	GO:0071277~cellular response to calcium ion	5	82	6.09756097560976	0.0382514951449511	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
up	WNT1; CCR2; HHEX;	GO:0009611~response to wounding	3	62	4.83870967741935	0.0390980235063638	0.1279883535054	1	1	0.982323498149493	0.982323498149493	1
down	RAB38; TBC1D8B; BVES; HSPA1B; SYT8; SYT12; ARL4D;	GO:0016192~vesicle-mediated transport	7	141	4.9645390070922	0.0395171025323373	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	ANXA8; RAB13; SNX33; TINAGL1; ANXA8L1;	GO:0016197~endosomal transport	5	83	6.02409638554217	0.0398739421088651	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	STXBP1; RAB3B; RAB13;	GO:0006904~vesicle docking involved in exocytosis	3	33	9.09090909090909	0.0407291187039756	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	NKX3-2; PITX2; BARX1;	GO:0048536~spleen development	3	33	9.09090909090909	0.0407291187039756	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
down	PLPP3; PLPP2; PCSK9; PLPPR5;	GO:0006644~phospholipid metabolic process	4	57	7.01754385964912	0.0409081512931224	0.108697302666993	1	1	0.999148947208221	0.999148947208221	0.958721468801706
up	FLT4; NCKAP1L; FOXC1;	GO:0048010~vascular endothelial growth factor receptor signaling pathway	3	64	4.6875	0.0421739947532254	0.1279883535054	1	1	0.982323498149493	0.982323498149493	1
up	IL18; IL23A; TLR7;	GO:1901224~positive regulation of NIK/NF-kappaB signaling	3	64	4.6875	0.0421739947532254	0.1279883535054	1	1	0.982323498149493	0.982323498149493	1
up	WNT1; FLT4; AIF1; ANGPT1; PROM2;	GO:0001934~positive regulation of protein phosphorylation	5	161	3.1055900621118	0.0435500638092902	0.1279883535054	1	1	0.982323498149493	0.982323498149493	1
down	ETV5; STXBP1; CHRNG;	GO:0007274~neuromuscular synaptic transmission	3	34	8.82352941176471	0.0436438067297984	0.112514562804094	1	1	0.999148947208221	0.999148947208221	0.992390098617215
down	SEC14L2; SREBF2; DHCR7;	GO:0045540~regulation of cholesterol biosynthetic process	3	34	8.82352941176471	0.0436438067297984	0.112514562804094	1	1	0.999148947208221	0.999148947208221	0.992390098617215
down	RBFOX2; DSCAM; LRP4;	GO:0048813~dendrite morphogenesis	3	34	8.82352941176471	0.0436438067297984	0.112514562804094	1	1	0.999148947208221	0.999148947208221	0.992390098617215
up	SSTR3; CNR2; HRH2;	GO:0007187~G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	3	65	4.61538461538462	0.0437562145621406	0.1279883535054	1	1	0.982323498149493	0.982323498149493	1
up	TYROBP; FASLG; UACA;	GO:0097190~apoptotic signaling pathway	3	65	4.61538461538462	0.0437562145621406	0.1279883535054	1	1	0.982323498149493	0.982323498149493	1
down	TF; BMP4; BMP7; INHA;	GO:0060395~SMAD protein signal transduction	4	59	6.77966101694915	0.0451938226590458	0.114491017402916	1	1	0.999148947208221	0.999148947208221	1
down	ERBB2; NOS1; PAX9; SFRP1;	GO:0071363~cellular response to growth factor stimulus	4	59	6.77966101694915	0.0451938226590458	0.114491017402916	1	1	0.999148947208221	0.999148947208221	1
up	ICAM3; CLEC10A; CLEC4C; CLEC4A;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	4	112	3.57142857142857	0.0453562083968941	0.128231849122106	1	1	0.982323498149493	0.982323498149493	1
up	PF4; TAL1; FUT3; SLA; LTK;	GO:0042127~regulation of cell population proliferation	5	163	3.06748466257669	0.0454384992002796	0.128268374078347	1	1	0.982323498149493	0.982323498149493	1
down	MEIS2; SOX2; MAB21L1;	GO:0001654~eye development	3	35	8.57142857142857	0.0466596372469107	0.117890040916397	1	1	0.999148947208221	0.999148947208221	1
down	KLK8; EMP2; SNCAIP;	GO:0008219~cell death	3	35	8.57142857142857	0.0466596372469107	0.117890040916397	1	1	0.999148947208221	0.999148947208221	1
down	ITGA2; SOX9; DOCK1;	GO:0010634~positive regulation of epithelial cell migration	3	35	8.57142857142857	0.0466596372469107	0.117890040916397	1	1	0.999148947208221	0.999148947208221	1
down	DLL1; EDN2; IRX3;	GO:0097009~energy homeostasis	3	35	8.57142857142857	0.0466596372469107	0.117890040916397	1	1	0.999148947208221	0.999148947208221	1
up	PTPN2; NLRP6; NDRG2;	GO:0070373~negative regulation of ERK1 and ERK2 cascade	3	67	4.47761194029851	0.0470082653455157	0.131894207319967	1	1	0.982323498149493	0.982323498149493	1
up	CEACAM6; DSG1; CD84; IGSF9B; NECTIN4;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	5	165	3.03030303030303	0.047375069764521	0.132721975749393	1	1	0.982323498149493	0.982323498149493	1
down	TERT; CAV2; RAB38; CXADR; EPAS1;	GO:0007005~mitochondrion organization	5	88	5.68181818181818	0.048606571250692	0.122646062916753	1	1	0.999148947208221	0.999148947208221	1
down	BCAR3; CAV2; BCAR1; FOXC2; BAIAP2;	GO:0008286~insulin receptor signaling pathway	5	88	5.68181818181818	0.048606571250692	0.122646062916753	1	1	0.999148947208221	0.999148947208221	1
up	UPK3A; VIL1; SPINK5;	GO:0030855~epithelial cell differentiation	3	68	4.41176470588235	0.0486777294184779	0.135959398330462	1	1	0.982323498149493	0.982323498149493	1
up	OSM; GATA1; TAL1;	GO:1902036~regulation of hematopoietic stem cell differentiation	3	68	4.41176470588235	0.0486777294184779	0.135959398330462	1	1	0.982323498149493	0.982323498149493	1
down	DLL1; LRP5; NPR1; EDNRA;	GO:0008217~regulation of blood pressure	4	61	6.55737704918033	0.0497203706817514	0.124142963066972	1	1	0.999148947208221	0.999148947208221	1
down	ANXA1; VCAM1; HES1; CD276;	GO:0042102~positive regulation of T cell proliferation	4	61	6.55737704918033	0.0497203706817514	0.124142963066972	1	1	0.999148947208221	0.999148947208221	1
